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ABSTRACT 
BACKGROUND: The oral health status of chronic renal failure (CRF) patients 
undergoing treatment is complex due to other comorbid conditions. These patients 
appear to be predisposed to a variety of dental problems such as periodontal disease, 
narrowing of the pulp chamber, enamel abnormalities, premature tooth loss and 
xerostomia. Renal replacement therapy can affect periodontal tissues such as gingival 
overgrowth in immunosuppressed renal transplantation patients and increased levels 
of plaque accumulation, calculus formation, gingival inflammation, possible increase 
prevalence and severity of periodontal diseases in CRF patients. The presence of 
undiagnosed periodontitis may have significant effect on the medical management of 
CRF patient. Periodontitis has been found to contribute to systemic inflammatory 
burden including the elevation of C-reactive protein (CRP) in the general population 
dental care as well as primary preventive measures seems to be neglected in these 
patients. 
AIM: This study compared the periodontal and dental health status of patients on 
renal transplant patients (RT), hemodialysis patients (HD) and pre dialysis patients 
(PD) with healthy controls (C). 
METHODS:   This case control, prospective, parallel design study was conducted at the 
Department of Periodontics, Sri Ramakrishna Dental College & Hospital, Coimbatore and 
at Sri Ramakrishna Hospital, Coimbatore Kidney Center, Coimbatore. This study 
includes 25 renal transplant patients, 25 hemodialysis patients and 25 pre dialysis 
patients compared with 20 healthy controls (C) of age ranging more than 35 years. The 
clinical parameters were assessed using Plaque Index (PlI), Gingival Index (GI), probing 
pocket depth (PPD), clinical attachment level (CAL), gingival bleeding index (GBI) and 
gingival overgrowth (GO). The statistical analysis was performed using one-way analysis 
of variance (ANOVA), Tukey Kramer analysis, inferential statistics, Pearson 
correlation analysis and Post Hoc test was applied. 
RESULTS: In this study, difference between the groups in Plaque Index (PlI), 
Gingival Index (GI), probing pocket depth (PPD), clinical attachment level (CAL), 
gingival bleeding index (GBI) and gingival overgrowth (GO) was statistical 
significant difference (p<0.01). Clinical changes show all independent variables 
increased in renal transplant group when compared to dialysis and pre dialysis 
patients. All variables were comparably low in control group. The mean value of 
clinical parameters although insignificant, CAL was statistically significant. So, there 
was a direct correlation between CRF and periodontal disease. 
CONCLUSION: CRF patients are characterized by gingival and periodontal 
diseases. The dental community's awareness of the implication of poor oral health 
within this population should be elevated and daily oral health maintenance should be 
reinforced. 
KEY WORDS:  
Chronic periodontitis; gingival inflammation; periodontitis;  renal transplant; dialysis;  
pre dialysis. 
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   Chronic kidney disease (CKD) also known as chronic renal disease is a 
progressive loss in renal function over a period of months or years. It is caused by 
damage of the functional unit of the kidney, the nephron. Diseases which cause the 
destruction of nephrons are diabetes mellitus, pyelonephritis, glomerulonephritis, 
nephrosclerosis, polycystic kidney disease and vascular collagen disease.
1 
CKD is 
defined by Kidney Disease Quality Outcome Initiative (K/DOQI) as kidney damage 
or glomerular filtration rate (GFR) < 60 ml/min/1.73m
2
 for 3months or more, 
irrespective    of cause (Levey et al. 2005). The normal adult GFR is approximately 
100-120 ml/min/1.73m
2 
body surface area.
2
 
 It is a worldwide major public health problem with its fast-growing number of 
patients with end stage renal disease and enhance in mortality and morbidity. The 
incidence of chronic renal failure (CRF) and end-stage renal disease (ESRD) is rising 
constantly because the repair of the damaged parenchymal tissues is rare (Berthoux 
et al. 1999). The end result of a reduced renal function is uremia, which is a metabolic 
state of toxicity, affecting many organs like gastrointestinal, cardiovascular and 
neuromuscular. The treatment of CRF includes dietary changes, correction of 
systemic complications and dialysis or renal transplant.  
In the last 3-4 decade, improvement in dialysis and renal transplant has 
reduced morbidity and mortality among patients with ESRD.
 
Because of increased life 
span, increasing number of such patients will focus on dental treatment. The incidence 
of a variety of soft and hard tissue conditions such as gingival inflammation,              
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gingival overgrowth, periodontal disease, enamel hypoplasia, pulp obliteration and 
osseous changes of the jaw seems greater among chronic renal failure patients.
3
 
Chronic Periodontitis is an infectious disease resulting in inflammation within 
the supporting tissues of the teeth, progressive attachment loss and bone loss.
4 
The 
primary etiological agent is predominantly gram negative anaerobic facultative 
bacteria within the subgingival biofilm, the majority of periodontal tissue destruction 
is caused by an inappropriate host response to those microorganisms and their 
products. The pathogenesis of periodontitis elicits the production of cytokines, 
prostaglandins and in some cases, acute phase reagents, such as C-reactive protein.  
Chronic inflammatory condition leading to the formation of periodontal pockets, 
destruction of deep collagenous structures of the periodontium and alveolar bone, 
excessive mobility of the teeth and their premature loss.
5
 
 Periodontal destruction is evident in children and adolescent predialysis CRF 
patients and periodontitis is further exacerbated during maintenance dialysis therapy. 
Moreover, the factors predisposing to periodontal disease and accelerating its 
progression are widespread in CRF. They encompass hyposalivation and xerostomia, 
impaired immunity and wound healing, alveolar bone destruction due to renal 
osteodystrophy, bleeding diathesis, diabetes mellitus, malnutrition and a state of 
general disability impairing oral hygiene.
6
 
With this background, the present study is designed to find the influence of 
chronic renal disease on oral and periodontal condition. 
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AIM OF THE STUDY: 
The aim of the study was to gain an insight of oral and periodontal finding in 
patients suffering from chronic renal failure. 
 
OBJECTIVE OF THE STUDY: 
• To evaluate the oral and periodontal status of chronic renal failure patients 
undergoing predialysis (PD), dialysis (D) and renal transplant (RT).  
• Compare the relationship between oral and periodontal variables among 
chronic renal failure (CRF) cases and non renal disease controls. 
• To assess gingival overgrowth in renal transplant patients. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
REVIEW OF 
LITERATURE 
                                                 REVIEW OF LITERATURE 
 
 Page 4 
 
 
With normal day-to-day variations in the intake of food and water, 
preservation of the internal environment requires the excretion of waste products from 
intestines, lungs, and skin contribute to the excretory capacity and balances the 
quantities ingested. The greatest responsibility for solute and water excretion is borne 
by the kidneys. 
ANATOMY AND PHYSIOLOGY OF KIDNEY  
The human kidneys are bean shaped organs located in the retroperitoneum at 
the level of the waist. Each adult kidney weighs approximately 160 g and measures 10 
to 15 cm in length. Coronal sectioning of the kidney reveals two distinct regions: an 
outer region, or cortex, and an inner region known as the medulla. Structures that are 
located at the corticomedullary junction extend into the kidney hilum and are called 
papillae. Each papilla is enclosed by a minor calyx that collectively communicates 
with the major calyces to form the renal pelvis. The renal pelvis collects urine flowing 
from the papillae and passes it to the bladder via the ureter.7 
                 
 
 
 
 
 
 
 
                                       Fig. 1.   Anatomy of the Kidney 
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Kidneys are one of the important organs of the body which are constituted 
from segmented nephrons, blood vessels, and filtering capillaries. Vascular flow to 
the kidneys is provided by the renal artery, which branches directly from the aorta. 
This artery subdivides into segmental branches to perfuse the upper, middle, and 
lower regions of the kidney. Further subdivisions account for the arteriole-capillary-
venous network or vas recta. The venous drainage of the kidney is provided by a 
series of veins leading to the renal vein and ultimately to the inferior vena cava.
2
 
 
 
Fig. 2.  Vascular supply to the Kidney 
The nephrons are the functional unit of kidney. Each nephron is structured by 
afferent arteriole, bunch of glomerular capillaries named glomerulus enters into the 
dilated, blind end of the nephrons (Bowman’s capsule) which filter large amounts of 
fluid from the blood and long tubule that converts the fluid to urine on the way to 
collecting duct, pelvis of the kidney efferent arteriole, proximal and distal tubules. 
The anatomy of the fenestrated endothelial cells in the glomerular capillary and 
epithelial cells in tubular systems are developed to filter the renal blood. Afferent 
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arteriole conducts blood to nephron and then it enters into a glomerular capillary for 
filtration of most amounts of fluid. The ratio of glomerular filtration rate (GFR) to 
renal plasma flow determines the filtration fraction.
8
 
                    
 
                                  Fig. 4. Structure of  the nephron 
FUNCTION OF KIDNEY 
The kidneys are vital organs for maintaining a stable internal environment 
(homeostasis). The kidneys have many functions, including regulating the acid-base 
and fluid-electrolyte balances of the body by filtering blood, selectively reabsorbing 
water and electrolytes, and excreting urine. In addition, the kidneys excrete metabolic 
waste products, including urea, creatinine and uric acid as well as foreign chemicals. 
Apart from these regulatory and excretory functions, the kidneys have a vital 
endocrine function, secreting renin, the active form of vitamin D and erythropoietin. 
These hormones are important in maintaining blood pressure, calcium metabolism 
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and the synthesis of erythrocytes, respectively. The most significant function is 
filtering plasma and eliminating substances and materials that are not needed for 
body. Indeed, the substances contain urea due to amino acids metabolism, creatinine 
from muscle creatine, uric acid from nucleic acids and products due to hemoglobin 
breakdown like bilirubin and metabolites of the hormones. Eventually, kidneys should 
remove these waste materials from the filtrate and blood and excrete approximately 
1.5 to 2.5 L of urine per day.
8
 
Under normal physiologic conditions, the kidneys serve several functions:
8
  
 Non excretory functions 
o Degradation of polypeptide hormones 
 Insulin 
 Glucagon 
 Parathormone 
 Prolactin   
 Growth hormone 
 Antidiuretic hormone 
 Gastrin 
 Vasoactive intestinal polypeptide 
o Synthesis and activation of hormones 
 Erythropoietin (stimulates erythrocyte production by bone 
marrow) 
 Prostaglandins (vasodilators that act locally to prevent renal 
ischemia) 
                                                 REVIEW OF LITERATURE 
 
 Page 8 
 
 Renin (important in regulation of blood pressure) 
 1,25-Dihydroxyvitamin D3 (final hydroxylation of vitamin D to 
its most potent form) 
 Excretory functions 
o Excretion of nitrogenous end products of protein metabolism (eg. 
creatinine, uric acid, urea) 
o Maintenance of ECF volume and blood pressure by altering Na+ 
excretion 
o Maintenance of plasma electrolyte concentration within normal range 
o Maintenance of plasma osmolality by altering water excretion 
o Maintenance of plasma pH by eliminating excess H+ and regenerating 
HCO3 
o Provision of route of excretion for most drugs  
CHRONIC KIDNEY DISEASE 
Chronic kidney disease (CKD) is a generalized term for a variety of chronic 
conditions that result in compromised kidney functions.
9
 In a healthy body, the acid-
base balance is maintained via buffers, breathing, and the amounts of acid or alkaline 
wastes in the urine this is because the daily load of endogenous acid is excreted into 
the urine with buffering compounds such as phosphates. When the kidneys are no 
longer able to maintain normal homeostasis it results in uremia caused by renal 
failure, retention of excretory products, and interference with endocrine and metabolic 
functions. As the GFR progressively decreases, the tubular excretory capacity for 
positive hydrogen (H
+
) ions is overwhelmed because renal ammonia production 
                                                 REVIEW OF LITERATURE 
 
 Page 9 
 
becomes inadequate. As the kidney deteriorates, metabolically derived acids 
accumulate results in acidosis leading to an increase in the anion gap.  
Disorders of the kidneys can be classified into the following diseases or stages:
42
 
1) Disorders of hydrogen ion concentration (pH) and electrolytes,  
2) Acute renal failure (ARF),  
3) Chronic renal failure (CRF),  
4) End-stage renal failure or uremic syndrome. 
Chronic Kidney disease has been defined according to the following criteria:
42
 
1. Kidney damage for ≥ 3 months, as defined by structural or functional abnormalities 
of the kidney, with or without decreased Glomerular filtration rate (GFR), manifest by 
either, pathological abnormalities or markers of kidney damage, including 
abnormalities in composition of the blood or urine, or abnormalities in imaging tests.  
2. GFR < 60 ml/ min/ 1.73 m
2 
for ≥ 3 months, with or without kidney damage.  
Table 1. Classification of kidney disease according to National Kidney 
Foundation According to National kidney foundation (2002) stages of chronic kidney 
disease  
STAGE DESCRIPTION GRF 
 (ml/ min/ 1.73 m
2
) 
1 Kidney damage with normal or ↑ GFR ≥ 90 
2 Kidney damage with mild ↓ GFR 60-89 
3 Moderate ↓ GFR 30-59 
4 Severe ↓ GFR 15-29 
5 Kidney failure (ESRD) < 15 (or dialysis) 
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Stages 3 and 4 can also be characterized by uremia, but usually in lower levels than stage 
5. Stage 5 is caused by any condition that could potentially destroy the nephrons. There 
are some diseases which cause the destruction of nephrons are diabetes mellitus, 
pyelonephritis, glomerulonephritis, nephrosclerosis, polycystic kidney disease and 
vascular collagen disease.
1
 
EPIDEMIOLOGY OF CKD  
Chronic kidney disease is a worldwide major public health problem with its 
fast-growing number of patients with end stage renal disease and enhance in mortality 
and morbidity. There are over one million dialysis patients worldwide, with an 
incidence of about a quarter of a million new patients each year. The incidence of 
patients with end-stage renal disease (ESRD) being treated by renal replacement 
therapy varies enormously depending on the level of affluence of the country.
11
 
The 
highly developed countries such as North America, Europe and Japan have the 
highest incident rates of treated end-stage renal disease, whereas the emerging 
countries have very low incident rates.
 
The huge disparity in the prevalence of ESRD 
between the more and less developed countries probably due to the inadequacy of 
health care system, racial and ethnic differences. About 90% of treated ESRD patients 
come from more developed countries that can still afford the cost of renal replacement 
therapy.
12
 In USA and Australia, the annual incidence of ESRD is significantly lower 
in whites than in African-Americans. The number of patients with ESRD probably 
underestimates the entire burden of the chronic kidney disease (CKD) because the 
number of subjects with early stage of the disease (stage 1 to 4) is likely to exceed by 
as much as fifty times those reaching ESRD.  
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In India, the prevalence of CKD was observed to be 17.2% with 
approximately 6% have CKD stage 3 or worse. It has been recently estimated that the 
age-adjusted incidence rate of ESRD to be 229 per million population (pmp), and 
>100,000 new patients who enter renal replacement programs annually.
13
 It is a major 
health burdens in United State and 1,06,912 patients tolerated ESRD during 2005. 
The prevalence of end-2 stage renal disease is higher in Japan followed by Taiwan 
and USA. In USA, the rate of patients who need treatment is estimated to enhance up 
to 60% by 2010.
63
 Premature death among people with CKD is three-fold higher than 
general population.  
Coresh et al. (2005)
15
 reported that 4.2% of individuals above 20 year-old had 
GFR 15 to 59 ml/min/1.73 m² in NHANESIII. 
PATHOLOGY OF CKD  
Type II Diabetic mellitus leads to diabetic nephropathy that is the most 
common cause of CKD and second cause being hypertensive nephropathy. The basis 
of nephrosclerosis caused by vascular disease is the same as which makes the 
coronary heart disease and cerebrovascular disease. Atherosclerotic vascular disease 
among the old patients is the manifestation of generalized vascular disease. The early 
stage of CKD is revealed by microalbuminuria and minor reduction in GFR which is a 
risk factor for CVD. The majority of this population does not show the last stages of 
CKD as they die due to cardiovascular and cerebrovascular diseases.
14
 
Chronic inflammation has been proposed as one of the probable pathologies 
for CKD. Chronic systematic infection leads to elevated inflammatory markers level 
including C-reactive protein (CRP), interleukin-6, haptoglobin and 
fibrinogen.
16
Microalbuminuria is the early manifestation of renal damage due to 
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endothelial dysfunction before decrease in GFR which later leads to 
macroalbuminuria and more advanced kidney failure manifested by decreased GFR.
17
 
INDICATORS OF CHRONIC KIDNEY DISEASE  
Early stage of CKD manifested with microalbuminuria which later leads to 
macroalbuminuria. Albuminuria is indicated by urinary albumin-to-creatinine ratio 
(ACR) which is reported in mg/g. Microalbuminuria is defined as ACR > 30 mg/g to 
less than 300 mg/g and individuals with ACR ≥300mg/g are classified as having 
macroalbuminuria. 
The recommendation of National Kidney Foundation and American Society of 
Nephrology is to use creatinine to estimate GFR (eGFR), within clinical settings. 
Among the young the normal range of GFR is 120-130 ml/min/1.73m² which 
decreases with age. CKD occurs with a GFR <60 ml/min/1.73m². The gold standard 
to determine the GFR in patients is to measure the clearance of insulin since it is not 
secreted by the renal tubules, but this remains an impractical test to perform clinically. 
Therefore, clinicians have relied on the measurement of serum creatinine as an 
indirect measure of the GFR and use creatinine-based formulae to calculate the GFR. 
There is a high degree of physiologic variability in GFR among normal individuals, 
thus making it difficult to define limits for normal GFR.
9
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Table 2. Normal range of laboratory test in chronic renal failure 
                      
EFFECT OF PERIODONTITIS ON CKD: 
PATHOGENESIS:  
Systemic inflammation is the proposed mechanism for the effect of 
periodontitis on the development of kidney disease. Cardiovascular diseases and CKD 
share same pathogenesis. Periodontal pathogens have the ability to adhere, invade and 
proliferate in coronary endothelial cells leading to atheroma formation and impaired 
vasculature relaxation. Host factors such as systemic diseases, genetic polymorphism 
or drug usage play a major role in the pathogenesis of periodontal disease by 
modifying the host response to periodontal infection or altering the susceptibility to 
infection by periodontal organisms. Chronic renal disease is associated with well-
documented impairments in polymorphonuclear leucocyte (PMN) function. Both 
periodontitis and kidney diseases are associated with inflammatory markers such as 
C-reactive protein and chronic low level inflammation associated with periodontitis 
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may lead to endothelial dysfunction which plays a role in the pathogenesis of kidney 
disease.
18
The deleterious effects of systemic inflammation on kidney function could 
occur during the period of active periodontal infection and accumulate during the life 
time of the individual.
19
 
ORAL MANIFESTATIONS OF CHRONIC RENAL FAILURE  
 
 Gingival Enlargement 
Gingival diseases modified by medications are increasingly prevalent because 
of the increased use of drugs known to induce gingival enlargement (e.g 
immunosuppressive drugs such as cyclosporine, calcium channel blockers such as 
nifedipine, verapamil, diltiazem and sodiumvalproate). It creates difficulties in 
speech, mastication, tooth eruption, and aesthetic problems. Clinical and microscopic 
features of the enlargements caused by the different drugs are similar. The growth 
starts as a painless, beadlike enlargement.  Gingival is mulberry shaped, firm, pale 
pink in color. It project from beneath the gingival margin, slowly increases in size 1-3 
months after initiation and spontaneous disappears. The development and severity of 
gingival enlargement in response to medications are patient specific and may be 
influenced by uncontrolled plaque accumulation, as well as elevated hormonal levels. 
(a) Immunosuppressants  
i) Cyclosporine induced gingival enlargement 
Cyclosporine is a potent immunosuppressive agent used to prevent organ 
transplant rejection and to treat several diseases of autoimmune origin. Clinical 
features of the enlargement starts as a painless, beadlike enlargement.  Gingival is 
mulberry shaped, firm, pale pink in color. It project from beneath the gingival margin, 
slowly increases in size 1-3 months after initiation and spontaneous disappears. 
                                                 REVIEW OF LITERATURE 
 
 Page 15 
 
Cyclosporine-induced gingival enlargement is more vascularized than phenytoin 
enlargement. Its mechanism of action is selectively and reversibly inhibits helper T 
cells, which play a role in cellular and humoral immune responses. Cyclosporine A is 
administered intravenously or by mouth and dosages greater than 500 mg/day to 
induce gingival overgrowth. Its occurrence varies from 25% to 70%. It affects 
children more frequently and its magnitude appears to be related more to the plasma 
concentration than patient's periodontal status. Gingival enlargement is greater in 
patients who are medicated with both cyclosporine and calcium channel blockers. In 
addition to gingival enlargement, cyclosporine induces other major side effects such 
as nephrotoxicity, hypertension, and hypertrichosis.  
 (ii) Tacrolimus  
Tacrolimus is a macrolide molecule which has been shown to have major 
potential as an alternative immunosuppressant to cyclosporine. When cyclosporine is 
replaced by tacrolimus, it eliminates the upregulation of cyclosporine induced 
essential polypeptide growth factors which are the important mediator for gingival 
overgrowth.
20
 Tacrolimus has been used effectively and is also nephrotoxic, but it 
results in much less severe hypertension, hypertrichosis, and gingival overgrowth. 
21
 
(b) Calcium Channel-blocker-induced Gingival Enlargement 
Calcium channel blockers are prescribed to renal allograft recipients to reduce 
hypertension and cyclosporine-induced nephrotoxicity. They are nifedipine, 
amlodipine, diltiazem, verapamil, oxidipine, felodipine, and nitrendipine causing this 
gingival enlargement. They inhibit calcium ion influx across the cell membrane of 
heart and smooth muscle cells, blocking intracellular mobilization of calcium. This 
induces direct dilation of the coronary arteries and arterioles, improving oxygen 
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supply to the heart muscle. It also reduces hypertension by dilating the peripheral 
vasculature. Nifedipine is one of the most often used drug that induces gingival 
enlargement in 20% of patients.
22
The presence of dental plaque may predispose to 
nifedipine-induced gingival enlargement, but is not essential to its development. The 
dihydropyridine derivative, isradipine, can replace nifedipine in some cases and does 
not induce gingival overgrowth. Nifedipine is also used with cyclosporine in kidney 
transplant recipients, and the combined use of both drugs induces larger overgrowths. 
 Oral Hygiene and Periodontal Disease 
Individuals receiving hemodialysis have poor oral hygiene, increased calculus 
and plaque deposits, premature tooth loss, localized suppurative osteomyelitis, 
secondary to periodontitis, attrition, recession, gingivitis and tooth mobility. 15% of 
45 Virginian individuals receiving had a good standard of oral hygiene observed in 
individual receiving hemodialysis.
23
 
 Xerostomia 
Xerostomia occurs in hemodialysis individuals due to restricted fluid intake, 
side effect of drug therapy and/or mouth-breathing, intake of alcohol containing 
mouth wash. Long-term xerostomia predispose to caries and gingival inflammation 
and give rise to difficulties with speech, denture retention, mastication, dysphagia, 
sore mouth, and dysgeusia infections such as candidosis and acute suppurative 
sialadenitis.
3
 
Gingival bleeding 
Dialysis patients have more bleeding on probing due to fibrinolysis defect at 
the level of plasminogen activation. The fibrinolysis defect in CRF deepens as renal 
function declines. The gingiva in individuals with CRF can be pale due to anemia.
24 
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 Oral Malodor/Bad Taste 
Uremic patients have an ammonia-like oral odor also called as uremic odor 
occurs in one-third of individuals receiving hemodialysis and some patients complain 
of an unpleasant and/or metallic taste, or a sensation of an enlarged tongue.
25
 
 Mucosal Lesions 
Individuals receiving dialysis have oral mucosal lesions, particularly white 
patches and/or ulceration, In particular, lichenplanus and oral hairy leukoplakia occurs 
as a consequence of the associated immunosuppression drugs. Uremic stomatitis may 
manifest as white, red, or grey pseudomembrane overlying painful erythema patches, 
while an ulcerative form is red with a 'pultaceous' covering. Oral mucosal macules 
and nodules also described in 14% of individuals receiving hemodialysis.
3
Oral hairy 
leukoplakia that occur secondary to drug-related immunosuppression although 
clinically and histopathologically similar, lesions lacking Epstein-Barr virus (EBV) 
have been observed with uremia. Other oral candidal lesions such as 
pseudomembranous (1.9%), erythematous (3.8%), and chronic atrophic candidosis 
(3.8%) also reported in immunosuppressed patients. 
Dental Anomalies 
Dental anomalies like delayed eruption of permanent teeth, enamel hypoplasia 
of the primary and permanent teeth, with or without brown discoloration can also 
occur, narrowing or calcification of the pulp chamber, dental caries observed in 
groups of patients with CRF.  
Bone Lesions 
Defects of calcium metabolism in CRF cause loss of hydroxylation of                                
1- hydroxycholecalciferol to active vitamin D (1,25- dihydroxycholecalciferol), 
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decreased hydrogen ion excretion (and resultant acidosis), hyperphosphatemia, 
hypocalcemia and resultant secondary hyperparathyroidism. Secondary 
hyperparathyroidism affects up to 92% of patients receiving hemodialysis. 
Hyperparathyroidism may present as a maxillary brown tumor, enlargement of the 
skeletal bases, or tooth mobility.  
TREATMENT OF CHRONIC KIDNEY DISEASE 
The treatment of CRF is often divided into 
(1) Conservative therapy aimed at delaying progressive renal dysfunction(including 
dietary management) 
(2) Renal replacement therapy (when conservative measures are no longer effective).  
When the patient is diagnosed with CKD stage 5, the goals of treatment are to 
maintain quality of life, control disease progression and prevent further 
complications. At this stage, treatment focuses on dietary modification in an effort to 
decrease the retention of nitrogeneous waste products and control fluid and 
electrolyte imbalances. When conservative treatment fails and the number of 
functional nephrons is reduced to the point when the kidneys can no longer filter the 
blood and adequately remove nitrogen-containing compounds, either renal 
replacement therapy or renal transplantation is necessary.  
Conservative therapy 
An early symptom is hypertension, which untreated leads to hypertrophy in 
the glomerular and tubular structures which in turn cause increased filtration and rapid 
progression of the renal dysfunction. The disturbance causes retention of metabolites 
and alterations of the electrolyte and water balance. Increasing serum urea levels 
appear parallel to the uremic symptoms. Uremic toxicity partly occurs due to 
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malnutrition, acidosis, infections, inflammation, comorbidity, or psychological 
factors. Once the extent of renal impairment is established and reversible causes are 
excluded, medical management is devoted to the elimination of symptoms and the 
prevention of further deterioration. Initial conservative therapy is directed toward 
managing diet, fluid, electrolytes, and calcium-phosphate balance and toward the 
prevention and treatment of complications. Dietary regulation of protein (20 to 40 
g/day) may improve acidosis, azotemia, and nausea. The restriction of protein reduces 
not only BUN levels but also potassium and phosphate intake and hydrogen ion 
production and also reduces the excretory load of the kidney, thereby reducing 
glomerular hyperfiltration, intraglomerular pressure, and secondary injury of 
nephrons. This restricted diet is often supplemented with multivitamins specific to the 
needs of the renal patient. Despite difficulties with hypertension, edema, and weight 
gain, salt and fluid excess and depletion must be avoided. Early renal insufficiency 
patients by restricting the intake of phosphate-containing foods and by supplementing 
the diet can prevent hyperphosphatemia.  
Dialysis 
The patient's blood is separated from the dialysis fluid (dialysate) by a membrane 
which allows water and toxins, but not blood cells, to pass out of the blood. There are 
two types of dialysis: hemodialysis and peritoneal dialysis (PD). Hemodialysis is the 
removal of nitrogenous and toxic products of metabolism from the blood by means of 
a hemodialyzer system.  In peritoneal dialysis, the peritoneal membrane acts as the 
filter, whereas, in hemodialysis, the membrane is within the dialysis machine.
26
 The 
dialysis system consists of a dialyzer, dialysate production unit, roller blood pump, 
heparin infusion pump and various devices to monitor the conductivity, temperature, 
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flow rate, and pressure of dialysate and to detect blood leaks and arterial and venous 
pressures Individuals commonly commence with peritoneal dialysis and may progress 
to hemodialysis, if renal function deteriorates further. In peritoneal dialysis, The 
Tenckhoff Silastic catheter has made peritoneal puncture for each dialysis 
unnecessary. The Tenckhoff catheter is a permanent intraperitoneal catheter that has 
two polyester felt cuffs into which tissue growth occurs. If used with a sterile 
technique, it permits virtually infection-free long-term access to the peritoneum. Most 
affected patients receive hemodialysis for up to 4 hrs, 2 or 3 times each week.
27 
Disadvantage of hemodialysis, it increases the risk of viral transmission such as HIV 
and hepatitis B and C and is costly. There are three major types of vascular access for 
maintenance hemodialysis: primary arteriovenous (AV) fistula, synthetic AV graft, 
and double-lumen, cuffed tunneled catheters. Arteriovenous fistulae in the arm are 
required for regular vascular access via widebore needles. The fistula is usually 
fashioned from a native vein however, it is sometimes necessary to use animal or 
synthetic grafts if the local anatomy is unsuitable. Two of the benefits of peritoneal 
dialysis are that heparinization is unnecessary and that there is no risk of air embolism 
and blood leaks. It also allows a great deal of personal freedom; for this reason, it is 
often used as the primary therapy or as a temporary measure. These features, along 
with its simplicity, make peritoneal dialysis safe for patients who are at risk when 
hemodialysis is used.  There are two types of peritoneal dialysis. Continuous 
ambulatory peritoneal dialysis (CAPD) requires 4 exchanges of approximately 2 liters 
throughout the day. An alternative method is automated peritoneal dialysis (APD), in 
which the dialysis fluid exchanges are carried out automatically by machine, during 
the hours of sleep (for 8-10 hrs). 
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Renal Transplantation 
However, all the improvements in techniques of dialysis are in fact only temporary 
treatment forms until renal transplantation, which is the ideal mode of treatment. For 
chronic renal failure renal allografts may be cadaveric or from living donors, either 
related or non-related (although those from living relatives give rise to the best 
prognosis). Cadaveric organs are allocated on the basis of HLA tissue-typing, ABO 
compatibility, and the age and size of the donor and recipient. Although allograft 
failure causes rejection, adverse drug side-effects may also be a contributing 
factor.
26
Immunosuppressant therapy is required to minimize the risk of allograft 
rejection. Prednisolone, azathioprine, cyclosporin, and tacrolimus are the commonly 
used agents.  
Schuller et al. (1973)
28
documented the periodontal status of allograft renal 
transplant individuals under immunosuppressive drug therapy mainly azathioprine 
(172.7mg) and cortisone [prednisone (24.5 mg)] for a duration of 4 to 60 months. 
Total number of patients examined in the study is 33 among them 26 male and 7 
females who are selected from Toronto western hospital (Canada) compared with 
normal individuals without renal disease. Russell's periodontal index, oral hygiene 
index, prednisone and azathioprine dosage are assessed. Finally, no association exists 
between plaque and severity of periodontal disease. Low relationship exists between 
quantity of calculus and severity of periodontal disease. No statistically significant 
coefficients of correlation were obtained between the periodontal index and dosage of 
drugs, negative correlations for dosage and duration of prednisone. 
Tollefsen et al. (1978)
29
compare the severity of gingival inflammation, in 
terms of the size of the cellular infiltrate in four categories of patients. First group is 
                                                 REVIEW OF LITERATURE 
 
 Page 22 
 
healthy subjects (C),  second group (CP) moderate accumulations of dental plaque, 
third group (UH) patients with uremia and in hemodialysis and  fourth group (IS) had 
received renal allografts and was kept on an immunosuppressive regimen. Serum IgG, 
IgA,IgM are analysed from third group and fourth group. Gingival biopsies were 
obtained from each subject. The connective tissue inflammation (CTI) scores were 
compared between the groups. Inspite abundant local plaque accumulations, the UH 
group displayed essentially the same CTI scores as plaque-free controls (C), while the 
fourth group showed a significantly lower CTI score. The CTI scores of the CP group 
were significantly higher than those of the third group, fourth group and C groups. 
 Kardachi et al. (1978)
30
document the gingival condition of a group of 
patients who received renal transplants and were taking immunosuppressive drugs to 
combat rejection phenomena. 20 dentate patients who received kidney transplants at 
the Queen Elizabeth Hospital, Adelaide, were examined. They are compared with 
control group of subjects not undergoing any drug therapy. The group includes 14 
males and 6 females with average age of 38.6 years. All members are receiving oral 
azathioprine and prednisone and at the time of the examination the average daily 
doses were 105 mg and 12 mg respectively for 1 to 10 years. 20 patients attending 
dental department [Royal Adelaide Hospital] selected as controls. This group includes 
7 males and 13 females and their ages ranged from 16 to 73 years. Gingival Index 
(GI) and the Plaque Index (PI) are recorded. Finally the results suggest the mean PI of 
the renal transplant recipients slightly exceeded that of the control group, but the 
difference was not statistically significant. By contrast the mean GI of the transplant 
recipients was significantly lower than that of the control group. 
                                                 REVIEW OF LITERATURE 
 
 Page 23 
 
Oshrain et al. (1979)
31
 studied the host response of patients under 
immunosuppressant drug as well as corticosteroid therapy to periodontal treatment. 
Subjects included (a) 20 renal transplant patients, (b) 20 dialysis patients and (c) 20 
healthy individuals. Plaque index (PI), gingival index (GI), pocket depth, gingival 
recession, gingival enlargement and periodontal destruction index (PDI) are recorded. 
The results suggest that all three groups exhibit the expected direct toxic effects of 
plaque antigens on periodontal tissues and hence GI and PDI, scores are similar. No 
significant differences among the three groups in plaque index, gingival index and 
periodontal destruction index. In the transplant and (to a lesser extent) dialysis groups, 
the degree of tissue response are dampened by the reduction in the numbers of 
immunocompetent cells and the subsequent paucity of complement generated 
components and lymphokines. 
Been et al. (1982)
32
 examined a prospective longitudinal study on periodontal 
status of 4 allograft renal transplant patients before and after 9 months. They also 
received immunosuppressive drugs as part of their therapy, beginning at the time of 
transplantation. 3 age matched hemodialysis patients and 6 patients free of systemic 
disease selected from eye clinic who were otherwise healthy selected as controls. 
Plaque index, pocket depths and gingival inflammation were assessed. The results 
suggest that the administration of the immunosuppressive drugs significantly reduces 
the level of gingival inflammation in the presence of high levels of bacterial plaque. 
No change in pocket depths either in the transplant patients or control. This study 
finally hypothesized that host inflammatory and immunological responsiveness to 
plaque bacteria is a primary factor in the pathogenesis of destructive periodontal 
disease in humans. 
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Nishikawa et al. (1991)
69
 reported gingival hyperplasia in 2 patients treated 
with nifedipine for more than 3 months selected from Department of Periodontology 
Tokushima University, Tokushima, Japan. Clinical findings and hispathological 
features induced by nifedipine on gingival fibroblastic cells. In the first case, plaque 
control and surgical removal of the overgrowth of gingival tissues without 
discontinuing drug administration resulted in satisfactory progress, it suggests that the 
preexisting gingival inflammation was involved in the development of this 
periodontal disease. In the second case, change from nifedipine to thiazide resulted in 
spontaneous recovery, suggesting that the drug had induced the gingival hyperplasia. 
Study of these 2 cases suggests that both local inflammatory factors and long term 
administration of nifedipine were responsible for the gingival hyperplasia.  
Yamalik et al. (1991)
70
 reported the histological investigation of gingiva from 
patients with chronic renal failure (CRF) undergoing hemodialysis and renal 
transplant recipients (RTR) treated with immunosuppressive drugs and systemically 
healthy controls. Plaque index is similar in all groups, the gingival index was 
significantly less in RTR when compared to the other 2 groups. In light microscopic 
investigation the appearance of the connective tissue, mononuclear cell infiltration 
was similar in all of the groups. Number of inflammatory cells in patients with 
periodontitis was significantly higher than the other 2 groups. Desquamation like 
appearance in the superficial layers of the oral epithelium seen in patients with CRF. 
In electron microscopic investigation, fibroblasts and plasma cells with well-
developed granular endoplasmic reticulum were found in connective tissue in RTR 
patients. In patients with CRF, epithelial cells presented swollen granular endoplasmic 
reticulum cisternae resembling vacuoles, indicating the presence of degeneration. It 
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was suggested that with the use of immunosuppressive drugs the response to bacterial 
plaque did not diminish completely. 
Khocht et al. (1996)
33 
compared periodontitis patient with chronic renal 
failure. Scaling and root planning along with apically positioned flap with osseous 
recontouring is done with 1-year follow up. The study reveals that periodontal 
infections in patients with depressed PMN function could still be managed 
successfully with standard periodontal treatment emphasizing plaque control. 
Conclusion of the study is periodontal management of CRF patients is to anticipate 
progression of renal disease and plan for continued periodontal care when the patient 
eventually reaches dialysis and/or transplantation stage. Patients on hemodialysis are 
systemically heparinized during treatment. To avoid potential bleeding problems, 
periodontal treatment should not be provided on the same day of dialysis treatment. 
Westbrook et al. (1997)
34
 evaluated the effect of nifedipine induced gingival 
hyperplasia (GH) of a switch to a dihydropyridine derivative with a low incidence of 
GH. 14 patients with nifedipine-induced GH were given a medical and periodontal 
examination. Probing depth (PD), gingival margin (GM), gingival thickness (GT), 
plaque index (PI), and gingival index (Gl) were assessed. Intraoral photographs, study 
models, and a gingival biopsy for histological examination were taken. Following 
baseline measures, patients were randomized to continued treatment with nifedipine 
or an equivalent dose of isradipine in a singleblind fashion. Biweekly periodontal 
parameters were taken for 8 weeks. At the end of 8 weeks, some patients elected to 
receive 4 weeks of open label isradipine therapy, with biweekly examination 
continuing through the open label phase. The isradipine treatment arm showed a mean 
decrease in PD. No other measured parameter (GM, GT, PI, GI) was significantly 
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changed, compared either to baseline or to the alternate treatment. Clinically, 60% of 
patients treated with isradipine exhibited a decrease in hyperplasia, while 66% of 
patients treated with nifedipine demonstrated an increase in hyperplasia. After 12 
weeks, no patients treated with isradipine exhibited an increase in gingival 
overgrowth.  
Naugle K et al. (1998)
23
 determined the oral health status of individuals 
undergoing renal dialysis in southeastern Virginia. Three subgroups of the population 
were studied: 1) dialysis for less than a year; 2) dialysis for 1 to 3 years; and 3) 
dialysis for longer than 3 years. Three dental indices (Periodontal Disease Index; the 
Decayed, Missing, Filling Index; and the Simplified Oral Hygiene Index) were used 
to identify periodontal disease, dental caries activity, and oral hygiene status. Data 
were compiled and analyzed by using the parametric test, one way analysis of 
variance. Results suggested that 100% (n = 45) of the individuals undergoing renal 
dialysis presented with some form of periodontal disease. 45 individuals displayed 
severe gingivitis (28%) or early periodontitis (>36%). 64% of the sample displayed a 
high DMF Index, while 15% of the sample had excellent calculus score. Oral debris 
was present in 100% of the sample, resulting in a high Simplified Oral Hygiene Index 
score, suggesting an increased need for oral care instruction. Findings lead to the 
conclusion that the renal dialysis population is in need of comprehensive professional 
oral care and self-care instruction. 
James et al. (2000)
71
 examined short term effect of conversion of 
cyclosporine to tacrolimus in 4 renal transplant patients and management of gingival 
overgrowth induced by cyclosporine A. Gingival overgrowth scores, intraoaral 
photographs and alginate impression were taken prior to drug conversion and 6 to 9 
                                                 REVIEW OF LITERATURE 
 
 Page 27 
 
months later. There was a reduction in overgrowth in the 4 renal transplant patients 
who switched from cyclosporine A to tacrolimus. One patient had complete 
regression. The author concluded that conversion of renal transplant patients with 
gingival overgrowth from cyclosporine A to tacrolimus may provide an effective 
management strategy for this clinical problem. 
Thomas et al. (2001)
72
 examined the medical and dental risk factors of renal 
transplant patients following administration of cyclosporine A and development of 
cyclosporine A induced gingival overgrowth. The 236 patients in this study comprised 
152 males and 84 females with a mean age of 46 years and a mean duration of renal 
replacement therapy of 477 days. The patients medicated with both traditional oral 
cyclosporine A (n =220 individuals) and the new microemulsion form (n=229 
individuals). Patients had either received cyclosporine A alone (n=45 individuals) or 
cyclosporine A and nifedipene (n=191 individuals. Gingival hyperplasia was present 
in 113 (48%) cases and the mean and maximum hyperplasia scores in affected 
individuals were 0.86 and 2.26.  Pre and post transplant medical history and post-
transplant renal function, i.e., serum creatinine levels, documented rejection episodes 
and glomerular filtration rates (GFR) gingival overgrowth was assessed. These data 
together with cyclosporineA serum levels and last-recorded dose of cyclosporineA, 
cyclosporineA microemulsion, nifedipene, azothioprine and prednisolone, were 
analysed. Results suggest that gingivitis and plaque were associated with hyperplasia. 
Duration of renal replacement therapy, age at transplantation, post transplant interval 
serum creatinine levels and documented rejection episodes were unrelated with the 
extent and severity of GH. GFR with last recorded doses of cyclosporineA and 
cyclosporine A microemulsion is significant. 
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Klassen et al. (2002)
3
 reported a questionnaire and a noninvasive oral 
examination from hemodialysis and peritoneal dialysis patients registered in the 
dialysis program. 226 dialysis patients in central and northern Saskatchewan, 147 
were interviewed and examined. Of these, 94 (64%) were dentate, and the same 
number had been on dialysis for a mean of more than 2 years; about a third were 
diabetic, almost all were hypertensive and all had non dental prosthetic devices or 
arteriovenous fistulae or both. 60 of the dentate patients were candidates for kidney 
transplantation. Most of the dentate patients reported brushing once or more daily, but 
they flossed infrequently or never. Dental visits were infrequent, less than every 5 
years in 59 (63%) of the dentate patients. Findings in the dentate group included 
increased tooth mobility, fractures, erosion, attrition, recession, gingivitis and a high 
plaque index. A patient’s dentist was contacted if the patient had seen him or her since 
starting dialysis (31 of the 94 dentate patients). Most (81%) of the dentists were aware 
that they were treating a dialysis patient. Medication records were incomplete for 29% 
of the patients, and only 2 (6%) of the patients had received antibiotic prophylaxis 
despite the fact that all had prosthetic devices or arteriovenous fistulae. Author   
concluded that the dental health of dialysis patients is poor and requires greater 
attention.  
Frankenthal et al. (2002)
67
 studied the effect of secondary HPT 
(hyperparathyroidism) on the periodontium of patients on hemodialysis. Experimental 
group consisted of 35 patients with secondary HPT, with chronic renal failure treated 
by hemodialysis (E group). Age and gender matched healthy control group (C group) 
are selected. Blood samples collected from E group, and the biologically active intact 
parathormone molecule, was assayed using two-site immunoradiometric assay 
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(IRMA). Clinical periodontal examination like Plaque index (PI), Gingival index 
(GI), Probing depth (PD) and Clinical attachment level (CAL) are recorded. A 
standardized panoramic X-ray was taken from all patients and computer-based linear 
measurements were used to assess alveolar bone loss. PI was also similar in the C and 
E group. GI is slightly greater in the C group compared to the E group. PD in the E 
group is almost identical to that of the C group. CAL in the E group did not differ 
from CAL in the C. It is concluded that secondary HPT does not have an appreciable 
effect on periodontal indices and radiographic bone height. 
Wahadni et al. (2003)
35
 examined periodontal disease and dental caries in 
individuals on renal dialysis in a Jordanian population. 47 individuals with a mean age 
of 42.9 years were examined for plaque deposits, gingivitis, periodontitis, and dental 
caries using the plaque index (Pl), gingival index (Gl), probing pocket depth (PPD), 
gingival recession and decayed, missing, or filling teeth (DMFT). Patients were 
categorized into three subgroups based on duration of renal dialysis as less than 1 
year, 1 to 3 years and longer than 3 years. The results suggest no statistically 
significant differences in Pl, Gl, PPD, and gingival recession among the three 
subgroups examined. This study displayed an absence of gingival inflammation, 
DMFT index showed that there were statistically significant differences between 
subjects on renal dialysis for less than 1 year and subjects on dialysis for 1 to 3 years 
and more than 3 years.  
Marakoglu et al. (2003)
1
 evaluate the clinical response of 36 chronic renal 
failure patients receiving hemodialysis to existing microbial dental plaque. Gingival 
Index (GI) and Plaque Index (PlI) scores and probing depths (PD) were recorded. 
They are compared with 36 systemically healthy individuals matched with the patient 
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group based on age and extent of plaque accumulation. No statistically significant 
difference between the two groups. In hemodialysis patients, response is similar to 
existing bacterial plaque and their periodontal status when compared with control 
group. It is concluded that chronic renal failure does not seem to be an additional risk 
factor for more severe periodontal destruction.  
Souza et al. (2005)
36
 evaluated the periodontal status of 30 patients and the 
amount of salivary IgA in chronic renal dialysis patients. Plaque, calculus and 
gingival indices are assessed. PSR and IgA in saliva are analysed. Results 
demonstrated plaque, calculus and gingival indexes were high in the studied group. 
Despite a greater accumulation of plaque, IgA in dialysis patients indicates 1/3
rd
 of 
that population have serum IgA concentrations below normal. Patients presenting 
chronic kidney disease disclosed a tendency for greater bacterial plaque 
concentration, high formation of dental calculus suggesting the need for periodontal 
treatment.  
Davidovich et al. (2005)
6
 describe the prevalence and severity oral diseases, 
and their relation to type, duration and severity of the renal disease, and their 
treatment modalities in a relatively large population of children, adolescents and 
young adults suffering from chronic renal failure. Four renal failure groups: chronic 
renal disease (n=22), undergoing dialysis (n=22), after dialysis and transplant (n=21) 
and after transplant (n=32), and a healthy control (n=38) were examined. Caries, 
enamel hypoplasia, pulp obliteration, Plaque Index, gingival bleeding, recession, 
overgrowth and index, probing depths, attachment loss, renal treatments and their 
relations with the oral variables were analysed. The renal failure groups had higher 
gingival index (GI) and bleeding on probing, probing depths and attachment loss, and 
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less caries, hypoplasia and obliteration than the control. Plaque was higher in the 
dialysis and pre-dialysis (PD) groups. Overgrowth was evident after transplant. The 
PD group showed lower GI than other renal groups. Dialysis duration and end-stage 
renal failure significantly correlated with gingivitis, probing depth, attachment loss 
and enamel hypoplasia. Immuran correlated positively with probing depth, gingival 
recession and attachment loss. Normiten and Nifedipine had positive correlations with 
gingival overgrowth. 
Kshirsagar et al. (2005)
66
 examined the cross sectional study to find the 
association in a general population sample from the Dental component (D-ARIC) of 
the Atherosclerosis Risk in Communities (ARIC) study.  The study included 5,537 
middle-aged black and white men and women. Periodontitis patients were categorized 
as healthy/gingivitis, initial, and severe. 2,276 individuals had initial periodontitis, 
and 947 individuals had severe periodontal disease. 110 individuals (2%) had renal 
insufficiency. Healthy/gingivitis, initial and severe periodontal disease were 
associated with a GFR less than 60 mL/min/1.73 after adjustment for important risk 
factors for CVD and CKD. Initial and severe periodontitis were associated with an 
elevated serum creatinine level.  
Bots CP et al. (2006)
37
 made a cross-sectional study and compared the oral 
health status of chronic renal failure patients (CRF) on renal replacement therapy with 
a matched population. 42 dentate CRF patients aged 25-54 years were matched with 
control group of 808 dentate subjects. The oral health status is assessed using decayed 
missing filling (DMF) index, pocket depth, bleeding on probing and presence of 
calculus. In CRF patients, calculus is significantly higher than in controls. The self-
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reported oral health questionnaire revealed increased TMJ problems, malodour in 
CRF patients than controls.  
Boraswki et al. (2007)
41
 compared the periodontal status of 3 groups of adult 
CKD patients: (i) undergoing maintenance HD (ii) treated with continuous 
ambulatory peritoneal dialysis (CAPD) and (iii) pre-dialysis CKD patients from north 
eastern Poland. 106 patients are enrolled among them 35 on HD with mean age of 56 
years, 33 on CAPD with mean age 51 years and 38 pre-dialysis CKD stage 2–5 with 
mean age 51 years. 2 control groups comprised 26 generally healthy individuals with 
advanced periodontitis and 30 subjects from general population. Gingival Index (GI), 
papillary bleeding index (PBI), Plaque Index (PI), loss of clinical attachment level 
(CAL) and community periodontal index of treatment needs (CPITN) were examined. 
The PI values were higher in HD, CAPD and periodontitis patients than in general 
population subjects. The GI and PBI also were uniformly higher in HD patients than 
in CAPD were highest in HD patients comparably to patients with periodontitis, and 
exceeded the values found in CAPD, pre-dialysis CKD and general population 
subjects. CPITN is higher in periodontal disease patients and controls when compared 
with each of the renal failure. 
Yoshihara et al. (2007)
38
investigated relationship between periodontal 
disease and chronic renal function in community dwelling elderly Japanese subjects. 
145 subjects with mean age of 77 years participated in this study. A periodontal 
examination and urine was collected over 24 hours and morning blood samples were 
taken. Serum creatinine clearance, volume of creatinine, volume of urine per 24 hours 
was used as blood and urinary markers of kidney function. Biochemical parameters of 
bone turnover were measured: urinary deoxypyridinoline (U-DPD) as a bone 
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resorption marker and serum osteocalcin (S-OC) as a bone formation marker. The 
number of remaining teeth, smoking habit, gender, use of interdental brushes or dental 
floss, volume of urine per 24 hours, and creatinine clearance per 24 hours were 
independent variables in the first test. In addition, the number of remaining teeth, 
smoking habits, gender, use of interdental brushes or dental floss, U-DPD, and S-OC 
were independent variables in the second test. Creatinine clearance per 24 hours and 
S-OC were significantly associated with % ≥6-mm CAL per person. The % ≥6-mm 
CAL was significantly associated with renal function and bone metabolism markers. 
Bayraktar et al. (2007)
39
 compared the periodontal and dental health status of 
patients on hemodialysis (HD) with healthy controls (C). 76 HD patients and 61 
controls were examined for plaque deposits, gingivitis, periodontitis, calculus 
accumulation and oral health status. There was no statistically significant difference in 
the measurement of probing pocket depths (PPD) in HD and C groups, but a highly 
significant difference was found for plaque index, gingival index (GI) and calculus 
surface index. There was a highly significant difference for GI and PPD scores 
between subgroups receiving HD for < 3 years or more. A positive correlation 
between time on dialysis and parameter of missing teeth, GI scores and measurement 
of PPD was found in the HD group. Decayed, missing and filled teeth index scores 
were higher in the controls than the HD group, with no statistical significance. The 
dental and periodontal health status of HD patients is comparable with healthy 
controls, but becomes worse with time on dialysis. Thus, oral health maintenance is of 
utmost importance in this patient group.  
    Shultis et al. (2007)
40
 investigate the effect of periodontitis on development 
of overt nephropathy and end-stage renal disease (ESRD) in type 2 diabetes.                
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≥ 25 years individuals residing in the Gila River Indian Community with type 2 
diabetes, one or more periodontal examination, estimated glomerular filtration rate 
≥60 ml/min/1.73 m² and no macroalbuminuria (urinary albumin-to-creatinine ratio 
≥300 mg/g) were identified. Of the 529 individuals, 107 (20%) had none/mild 
periodontitis, 200 (38%) had moderate periodontitis, 117 (22%) had severe 
periodontitis, and 105 (20%) were edentulous at baseline. During follow-up of up to 
22 years, 193 individuals developed macroalbuminuria and 68 developed ESRD. 
After adjustment for age, sex, diabetes duration, BMI, and smoking in a proportional 
hazards model, the incidences of macroalbuminuria were 2.0, 2.1, and 2.6 times as 
high in individuals with moderate or severe periodontitis or those who were 
edentulous, respectively, compared with those with none/mild periodontitis. 
Incidences of ESRD in individuals with moderate or severe periodontitis or in those 
who were edentulous were 2.3, 3.5, and 4.9 times as high, respectively, compared 
with those with none/mild periodontitis. 
Castillo et al. (2007)
42
 in a cross-sectional study evaluated the periodontal 
status and oral microbiological patterns in population with end-stage renal disease 
(ESRD), undergoing haemodialysis (HD). This study involves 52 patients from the 
Nephrology Department and 52 matched control subjects. The subjects had a 
periodontal clinical examination, subgingival plaque samples were taken and analysed 
using a semiquantitative polymerase chain reaction (PCR) test to detect Porphyromas 
gingivalis, Tannerella forsythia, Prevotella intermedia, Prevotella nigrescens and 
Actinobacillus actinomycetemcomitans. Subgingival plaque and saliva samples were 
studied for Candida and Enterobacteriaceae. Outcome measures of 104 subjects had 
loss of periodontal attachment (LPA) ≥ 3 mm. Only 13 subjects (12.5%) presented 
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good periodontal health. No statistically significant differences were found between 
the HD patients and the control group regarding bleeding index, number of teeth or 
percentage of LPA ≥ 3 mm.  HD patients presented a higher number of 
periodontopathic microorganisms than the matched control group, a prolonged 
duration of HD did not bear a statistically significant relationship with the percentage 
of sites with LPA ≥ 3 mm, specific microbiota or composition of biofilm.  
Kshirsagar AV et al. (2007)
43
 in a case control study, observed an association 
of severe periodontal disease and hypoalbuminemia in a group of patients who were 
receiving long term hemodialysis. The relationship between periodontitis and 
measures of systemic inflammation, serum albumin and C-reactive protein (CRP), 
were examined. 6 sites per tooth (up to 32 teeth per patient) were examined. A total of 
154 patients mean age was 54.6 years completed the study. The average duration of 
dialysis was 4.0 years. 86 (54.6%) were men, and 89 (58.2%) were black. Common 
causes of end-stage kidney disease were hypertension (12.3%), diabetes (22.1%), 
glomerulonephritis (7.1%) and other (58.4%). 35 (23%) patients were periodontitis 
cases. Severe periodontitis was associated with low serum albumin compared with 
individuals without severe periodontitis disease after adjustment for age, gender, race, 
diabetes, hypertension, body mass index, smoking, study site, total cholesterol, serum 
calcium, serum phosphorus, and normalized protein catabolic rate. Increased levels of 
plaque have been reported for hemodialysis (HD) populations. There was no observed 
association of severe periodontitis with CRP. 
Fisher et al. (2007)
44
 conducted a cross-sectional, retrospective design study 
in 12,947 subjects (6922 female) with >18 years of age were enrolled in the study. 
Clinical (PPD, CAL and BOP) and microbiological periodontal examination and 
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laboratory tests were analysed. Chronic kidney disease prevalence was 3.6%, 
periodontal disease prevalence was 6.0%, and edentulism prevalence was 10.5%. 
Adults with periodontal disease and edentulous adults were twice as likely to have 
chronic kidney disease after simultaneously adjusting for other traditional and 
nontraditional risk factors. 
Fisher et al. (2008)
45
suggested periodontal infection contributes to chronic 
kidney disease in United States population. 4,053 adults ±40 years of age were 
included. Clinical measures and serologic markers of periodontal infection were 
investigated. 9% of the study population had chronic kidney disease, 22% had high A. 
actinomycetemcomitans antibody titer, 24%had high P. gingivalis antibody titer, 9% 
had periodontal disease and 17% were edentulous. After simultaneously adjusting for 
recognized risk factors, adults with a high A. actinomycetemcomitans titer were less 
likely to have chronic kidney disease and adults with edentulism were more likely to 
have chronic kidney disease. These results support considering edentulism and low 
serum titer to A.actinomycetemcomitans as risk indicators for chronic kidney disease. 
Joseph et al. (2009)
46
 assessed the prevalence of periodontal disease among a 
group of patients with renal disease and compared their periodontal status to that of 
healthy controls. 77 patients with different forms of renal disease and 77 healthy 
controls were examined for oral hygiene status, gingival inflammation, probing 
pocket depth and clinical attachment loss. The subjects were grouped into three as 
no/mild, moderate and severe periodontitis. All periodontal parameters were 
significantly elevated in the case group as compared to controls (p < 0.001).  
Nadeem et al. (2009)
47
 investigate the association of periodontal disease with 
increased systemic inflammation reflected by CRP values, in patients with ESRD on 
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maintenance haemodialysis (HD) or peritoneal dialysis (PD). 80 patients with mean 
age of subjects was 50.3±9.06 years with a median time on dialysis therapy of 24 
months who were in ESRD were included in the study. 42.5% subjects were male and 
62% subjects reported their race as coloured. Plaque index (PlI) gingival index (GI), 
bleeding on probing (BoP), probing depths (PD) and clinical attachment loss (CAL) 
were assessed. 57.5% subjects were diagnosed to have periodontal disease, of these 
52.2% had elevated CRP levels. 34 subjects with a healthy periodontium, only 29.4% 
had elevated CRP levels. The results of the study showed significantly elevated levels 
of CRP in ESRD patients with periodontitis.  
A study by Graziani et al. (2010)
48
 examined the effect of non-surgical 
periodontal treatment (PT) in subjects with generalized chronic periodontitis (GCP).  
20 GCP systemically healthy subjects were treated with PT. Serum samples were 
collected at baseline, 1 day, 7, 30, 90 and 180 days after treatment. GFR was 
evaluated using cystatin C, a serum marker and modiﬁcation of diet in renal disease 
(MDRD), an equation involving creatinine, urea and albumin. Serum markers of 
systemic inﬂammation such as C-reactive protein (CRP), D-dimer, serum amyloid A 
(SAA) and ﬁbrinogen were also assessed. The cystatin C level decreased igniﬁcantly 
from baseline to the end of the trial. Conversely, MDRD did not vary. Greater 
increases were noted for CRP and SAA within 24 h, while D-dimer and ﬁbrinogen 
showed mild variations. The values of inﬂammatory markers were normalized after 
30 days. 
Artese et al. (2010)
49
 hypothesised CKD predialysis patients with 
periodontitis would respond poorly to periodontal treatment owing to immunologic 
compromise. 21 predialysis patients (group 1) and 19 individuals without clinical 
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evidence of kidney disease (group 2) with chronic periodontitis were subjected to 
non-surgical periodontal treatment with no antibiotics. Clinical periodontal and 
systemic parameters were evaluated at baseline and 3 months after treatment. Both 
groups showed significant and similar post-treatment improvements in all periodontal 
parameters examined. Periodontal treatment had positive effect on the glomerular 
filtration rate of each individual. Results indicate that chronic periodontitis in 
predialysis kidney disease patients improved similarly in patients with chronic 
periodontitis without CKD after receiving non-surgical periodontal therapy. This 
study demonstrates that CKD predialysis patients show a good response to non-
surgical periodontal treatment. 
Iwasaki et al. (2011)
50
  made an adjusted multivariate regression model (for 
serum creatinine level, mean GFR, sex, lower income, lower education, status of 
visits to a dentist,   high alcohol consumption, smoking, proteinuria, hyperglycaemia, 
hypertension, hypercholesterolemia, hypertriglyceridemia, low HDL cholesterol level 
and obesity). Subjects were classified according to the amount of inflamed 
periodontal tissue. Results of the pooled analysis indicated a statistically significant 
risk of CKD for subjects with periodontitis. 
Grubbs et al. (2011)
19
made a cross-sectional study analysis of 2001 to 2004 
National Health and Nutrition Examination Survey data in U.S. population. These 
analyses included 6199 dentate adult participants (aged 21 to 75 years) with 
periodontal exams. The estimated prevalences of moderate/severe periodontal disease 
and CKD were 5.3% and 10.6%, respectively. Periodontal disease was associated 
with >2 fold higher risk of CKD that was moderately attenuated after adjustment for 
age, gender, race/ethnicity, tobacco use, hypertension, diabetes, educational 
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attainment, poverty index ratio, and dental care use. There were no statistically 
significant interactions between periodontal disease and race/ethnicity, educational 
attainment, or poverty status. 
Anees et al. (2011)
51
 conducted on patient on maintenance hemodialysis for 
more than 3 months at 3 dialysis centers of Lahore. 50 healthy individuals were 
included as controls from among the patients caregivers.  89 patients (71.2%) were 
men, 99 (79.2%) were married, 75 (60.0%) were older than 45 years, and 77 (61.6%) 
were on dialysis for more than 8 months. Patients on hemodialysis had a poorer QOL 
as compared to their caregivers in all domains except for domain 4 (environment). 
There was no difference in the QOL between the three dialysis centers of the study, 
except for domain 3 (social relationship) of the patients at Mayo Hospital (a public 
hospital), which was significantly better. Nondiabetic patients had a better QOL in 
domain 1 (physical health) as compared to diabetic patients. Duration of dialysis had a 
reverse correlation with the overall QOL.  
Brotto et al. (2011)
52
 made a cross sectional case control study and found the 
association between periodontitis and renal insufficiency by assaying kidney disease 
markers. Variables used to diagnose periodontitis were: (i) probing pocket depth 
(PPD), (ii) attachment loss (CAL), (iii) bleeding on probing (BOP) (iv) Plaque Index 
(PI) and (v) extent and severity index. Blood and urine were collected from 60 
apparently healthy non-smokers (men and women), consisting of a test group of 30 
subjects with periodontitis (age 46±6 yrs) and a control group of 30 healthy subjects 
(age 43±5 yrs). Kidney function markers (urea, creatinine, uric acid and albumin 
contents) were measured in the serum and urine. Also, the glomerular filtration rate 
was estimated from creatinine clearance, albumin: creatinine ratio in a 24–h sample of 
                                                 REVIEW OF LITERATURE 
 
 Page 40 
 
urine. Results was found that the control group had a greater mean number of teeth 
than the test group and that the two groups also differed in PPD, CAL, BOP and PI, 
all these variables being higher in the test group. For the extent and severity index of 
both PPD and CAL, the test group had much higher medians of both extent and 
severity than the control group. With regard to kidney function, none of the markers 
revealed a significant difference between the control and test groups and all measured 
values fell within the reference intervals. It is proposed that severe periodontitis is not 
associated with any alteration in kidney function.  
Vilela et al. (2011)
53
 reported an interventional, non-randomized controlled 
trial to determine the impact of periodontal therapy on level of serum prohepcidin (the 
prohormone of hepcidin) and inflammatory markers in chronic kidney disease patients 
and correlates in patients with chronic periodontitis. This study included 56 chronic 
periodontitis patients, 36 with chronic kidney disease and 20 without systemic 
diseases and with normal renal function (control group). The inflammatory markers 
ultrasensitive C-reactive protein, interleukin-6, and prohepcidin were evaluated before 
and 3 months after periodontal treatment. Periodontal treatment resulted in significant 
reductions in ultrasensitive C-reactive protein, interleukin-6 and serum prohepcidin 
levels in both the groups.  
Brito et al. (2012)
54
 made a cross sectional study and determine the extent and 
severity of periodontitis in chronic kidney disease patients undergoing the following 
three different treatment modalities: predialysis, continuous ambulatory peritoneal 
dialysis (CAPD), and hemodialysis (HD) and to compare the findings with those from 
systemically healthy individuals. A total of 198 individuals among them 40 CAPD 
patients, 40 HD patients, 51 predialysis patients and 67 healthy individuals were 
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examined. The periodontal examination included plaque index, probing pocket depth, 
clinical attachment loss and bleeding on probing. Patients with at least 4 sites with 
clinical attachment loss ≥ 6 mm were considered to have severe chronic periodontitis, 
and those with > 30% of sites with clinical attachment loss ≥ 4 mm were considered 
to have generalized chronic periodontitis. Predialysis and HD patients had 
significantly more sites with clinical attachment loss ≥ 6 mm than healthy individuals. 
The CAPD patients had generalized chronic periodontitis similar to healthy subjects. 
There were significantly more cases of severe chronic periodontitis in predialysis and 
HD patients. 
Manjunath et al. (2013)
55
 studied the influence of periodontal health on renal 
dialysis patients. 234 patients undergoing renal dialysis among them 60 % male and 
40 % female were included in the study. Periodontal disease status was measured by 
CPITN (Community Periodontal Index of Treatment Needs). Other parameters 
includes age, sex occupation, family history, history of other systemic diseases, 
medication taken, number of dialysis undergone, type of dialysis, history of renal 
transplant, personal history included oral hygiene status and loss of teeth was 
assessed. The author concluded that the prevalence of moderate to severe gingivitis 
and moderate periodontitis are seen in renal dialysis of patients. The population needs 
comprehensive oral and periodontal care. 
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STUDY DESIGN AND PATIENT SELECTION 
 
This study was designed as a multicenter, cross sectional, prospective, parallel 
design study conducted over a period of 3 months. Test group were selected in the 
Department of Nephrology, Sri Ramakrishna Hospital and Coimbatore Kidney 
Center, Coimbatore and controls obtain from Department of Periodontology, Sri 
Ramakrishna Dental College and Hospital, Coimbatore. The ethical clearance was 
obtained from the institutional ethical committee. The study included 75 cases of 
chronic renal failure patients compared with 20 healthy individuals who had no 
systemic disease. 
STUDY ETHICS AND SAFETY: 
 
This clinical study followed the principles in the Declaration of Helsinki. 
Approval from the institutional Review Board (IRB) and Ethical Committee 
(EC) of Sri Ramakrishna Dental College and Hospital was obtained prior to 
implementation. The subjects enrolled in this study had to satisfy the 
following criteria, 
CRITERIA OF INCLUSION: 
Test group with chronic renal failure patients: 
  Undergoing dialysis  
  Predialysis  
  Renal transplant patients 
Control group: 
 Patients received treatment in dental hospital 
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 No systemic disease 
STUDY GROUPS: 
After considering the inclusion and exclusion criterias, 75 patients in the test 
group were further divided into three groups based on their treatment.  
1. Group-I comprised of 25 patients who were on predialysis.  
2. Group-II comprised of 25 patients who were on dialysis.  
3. Group-III consists of 25 patients who underwent renal transplant.  
20 patients were included in the control group. 
ARMAMENTARIUM:   
DIAGNOSTIC INSTRUMENTS: 
1. Dental mouth mirror 
2. William’s periodontal probe 
3. Dental Explorer 
4. Tweezer  
5. Sterile cotton pellets 
6. Surgical mask & Head cap  
7. A pair of examination gloves 
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CLINICAL EXAMINATION: 
On every examination, the following clinical parameters were scored: 
i) Plaque Index (PlI): Full mouth plaque score was recorded by using 
Plaque Index given by Silness and Loe (1964).
56
 
ii) Gingival index (GI): Full mouth gingival score was recorded by using 
Gingival Index given by Loe and Silness (1963).
57
 
iii) Gingival bleeding index (GBI): Full mouth gingival bleeding score was 
recorded by using Gingival bleeding index given by Muhlemann & Son 
(1971).
58  
iv) Periodontal pocket depth: 
Conventional probing depth: The probing pocket depth was assessed 
in each tooth from the gingival margin to the base of the sulcus using Williams 
periodontal probe at six specific sites.
59
 
1. Distofacial line angle to the midline of distal surface 
2. Facial surface 
3. Mesiofacial line angle to the midline of mesial surface 
4. Distolingual line angle to the midline of distal surface 
5. Lingual surface 
6. Mesiolingual line angle to the midline of mesial surface 
v ) Clinical attachment level: From the cemento enamel junction (CEJ) to the 
base of the pocket in all the 6 sites using Williams periodontal probe as mentioned for 
probing depth.
60
 
1. Gingival margin located on the anatomic crown- subtracting the depth 
of pocket from the gingival margin to cementoenamel junction 
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2. Gingival margin coincides with cementoenamel junction the loss of 
attachment equals to the pocket depth 
3. Gingival margin located apical to cementoenamel junction the distance 
between the cementoenamel junction and gingival margin should be added to the 
pocket depth 
vi)  Gingival overgrowth: (GO) 
Gingival overgrowth is scored dichotomously, as either present or absent. For 
each tooth, a score of 1 was given, if GO was present at the clinical examination, 
and if GO was absent the score was 0. The average GO score per subject was 
calculated based on the number of sites exhibiting GO and the total number of 
sites evaluated.
61
 
vii) Radiographic assessment: The radiographic evidence of bone loss was 
determined if the distance from CEJ to the alveolar crest was > 2mm. 
62
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DEPARTMENT OF PERIODONTICS AND ORAL IMPLANTOLOGY 
ORAL AND PERIODONTAL STATUS IN PATIENTS 
SUFFERING FROM RENAL FAILURE 
                                                          PROFORMA 
                                           FORM I - SCREENING PROFORMA 
    NAME: 
     AGE:   SEX: 
     POSTAL ADDRESS: 
 
     TELEPHONE NUMBER: 
     OCCUPATION: 
CRITERIA OF INCLUSION: 
SELECTION OF CHRONIC RENAL FAILURE PATIENTS : 
 Number of patients undergoing dialysis : 25 
 Number of predialysis patients : 25 
 Number of renal transplant patients : 25 
 Age of the patient : >35 years 
SELECTION OF CONTROLS : 
 Number of subjects : 20 
 Age group > 35 years 
 No systemic disease 
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                                FORM II- HISTORY PROFORMA 
 
Chief complaint with duration: 
                                                                                          Absent                          
Present 
 
1. Bleeding gums                                                                 
2. Bad breath  
3. Pain in gums   
4. Swollen gums 
5. Pus discharge from gums 
6. Mobility 
7. Hypersensitivity 
8. Any other complaint’s (Specify):    
PERSONAL HISTORY:   
 1. Brushing habit:  
 2. Smoking:       Yes                                            No 
 3. Drug history : 
Dosage :        
 Duration : 
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                 FORM III- CLINICAL ASSESSMENT 
                                                                                                   DATE: __________ 
1. PLAQUE INDEX (SILNESS AND LOE 1964): 
 
 
 
 
Calculation:         
                        
 
 
Calculation  : 
 
 
Inference:          ------------------                                Excellent: 0 
                                                                                             Good: 0.1 – 0.9   
                                                                                             Fair: 1.0 – 1.9 
                                                                                              Poor: 2.0-3.0           
 
     
  
    
    Sum of score of each teeth 
 Total number of teeth examined 
 
       Sum of score of each teeth 
   Total number of teeth examined 
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2. GINGIVAL INDEX: (LOE & SILNESS 1963) 
 
 
 
 
 
 
 
 
Calculation  :   
     
 
 
Inference :       ------------------             Mild gingivitis: 0.1 - 1.0 
                                                                        Moderate gingivitis: 1.1 – 
2.0   
                                                                        Severe gingivitis: 2.1 – 3.0 
                    
  
       Sum of score of each teeth 
   Total number of teeth examined 
 
       Sum of score of each teeth 
   Total number of teeth examined 
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3. PERIODONTAL STATUS 
a) PROBING DEPTH (CONVENTIONAL PROBING METHOD) 
 
 
 
 
 
 
b) CLINICAL ATTACHMENT LEVEL  
 
                
                
48     47       46      45       44       43       42       41       31        32       33         34        35       36       37       38    
c ) GINGIVAL BLEEDING INDEX (GBI) (MUHLEMANN & SON 1971) 
 
18     17       16      15       14       13       12       11       21        22       23         24        25       26       27       28   48     
47       46      45       44       43       42       41       31        32       33         34        35       36       37       38    
  
 
 
 
               
 
 
 
               
18     17       16      15       14       13       12       11       21        22       23         24        25       26       27       28    
28    
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d) GINGIVAL OVERGROWTH  
 
e) LABORATORY DATA IN THE CRF SUBGROUPS 
 
f) RADIOGRAPHIC ANALYSIS : 
                                              
Creatinine                                  :                                mg/dL 
Blood urea                                 :                                mg/dL 
Calcium                                     :                                mg/dL 
Albumin                                    :                                g/dL 
Phosphate                                 :                                mEq/dL 
          Alkaline phosphatase               :                                   IU/L 
          Uric acid                                   :                                 mg/dL 
          Hemoglobin                              :                                  g/dL 
          Bicarbonate                               :                                mEq/dL 
          Potassium                                  :                                mEq/dL 
          Sodium                                      :                                mEq/dL 
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FORM V 
                                       CONSENT FORM 
                          CERTIFICATE BY INVESTIGATOR 
 
I certify that I have disclosed all details about the study in the terms easily understood 
by the patient. 
Dated:   ___________                                              Signature:  ______________ 
                                                                                   Name: __________________ 
                                    
                                 CONSENT BY SUBJECT 
 
                 I have been informed to my satisfaction, by the attending physician, the 
purpose of the clinical trial and the nature of treatment and follow up including the 
laboratory investigation to be performed to monitor and safe guard my body 
functions. 
 
Dated: _________                  Signature or thumb impression: _____________ 
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      Fig. 4.  Armamentarium for clinical examination 
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Fig. 5. Clinical examination 
 
      
Fig. 6. Patient undergoing dialysis                  Fig. 7. Dialysis machine 
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                               Fig. 8. Drug protocol for renal transplant patients 
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This study was a multicentered, cross sectional, prospective, parallel design 
study and purposive non probability sampling technique was applied. Statistical 
analysis used in this study is descriptive (frequency), inferential statistics like mean, 
standard deviation and ANOVA, to examine the significance of the differences 
between the clinical parameters among different groups. When a difference was 
found, a Tukey Kramer analysis for multiple regression analysis was utilized to 
elucidate which groups were statistically different from the others. The Pearson 
correlation analysis was utilized to examine the significance of the correlation 
between the variables. The statistical analysis was calculated by using analysis of 
variance (ANOVA) and Post Hoc test was applied for multiple comparisons. A          
p value=0.01 was chosen as level of significance.  The observation of the study is 
given as follows.  
Sample characteristics:  
Description of age in study group: 
Total number of individuals included in this study were 95 (CRF patients=75, 
Control=20), among them 68.4% were males (n=65) and 31.6% were females (n=30). 
In CRF groups, the total number of renal transplant (RT) patients were 25, among 
them 80% were males (n=20) and 20% were females (n=5). Total number of dialysis 
(D) patients were 25, among them 56% were males (n=14) and 44% were females 
(n=11). In predialysis group (PD), total number of patients were 25, among them 72% 
were males (n=18) and 28% were females (n=7). The total number patients in control 
group (C) were 20, among them 65%were males (n=13) and 35% were females (n=7) 
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[Table 1]. Association between the groups was given by Pearson Chi-Square which 
denotes (p<0.01).The individuals age between the group was statistically significant. 
Description of gingival overgrowth: 
In this study, 52% (n=13) of renal transplant (RT) patients, 12% (n=3) dialysis 
(D) patients and 4% (n=1) predialysis (PD) patients showed significant amount of 
gingival overgrowth. No patients in the control group (C) (0%, n=0) had gingival 
overgrowth. Pearson Chi Square denotes the association within the groups was 
statistically significant value (p<0.01) as shown in [Table 2]. 
Description of clinical parameter in study groups: 
 The mean values among the CRF groups indicate that there was no significant 
difference in GBI, PPD, GI and PlI which was done using ANOVA analysis. The 
mean value of PlI in RT group was 1.7096, D group was 1.4032, PD group was 
1.2872 and C group was 0.6075 which were statistically insignificant (p = 0.036). 
Similarly, the mean values of GI in RT, D, PD, C group was 1.8220, 1.5064, 1.3048, 
0.5965 respectively were also statistically insignificant (p = 0.078). For PPD, the 
mean values in RT, D, PD, C group was 3.9708, 3.8084, 3.5016, 2.8250 respectively 
but these values were statistically insignificant (p = 0.306). The mean value of GBI in 
RT, D, PD, C was 2.9268, 2.4728, 2.3124, 1.1960 respectively but these values were 
statistically insignificant (p = 0.476). In contrast with other clinical parameters, the 
mean value of CAL in RT, D, PD, C is 2.3020, 1.6008, 0.4832, 0.0750 were 
statistically significant (p = 0.000). As shown in Table 3, the clinical parameters of 
the study group like PlI, GI, GBI, PPD were statistically insignificant and only 
statistically significant parameter was CAL.  
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Description of intergroup comparison in the study groups: 
 The mean difference of independent variable PlI was statistically significant 
between RT and PD (p=0.019), RT and C (p=0.000), D and C (p=0.000), PD and C 
(p=0.000) [Table 4, Fig 1] and statistically insignificant values between RT and D 
(p=0.142), PD and D (0.846).  
The mean difference of independent variable GI was statistically significant 
between RT and PD (p=0.001), RT and C (p=0.000), D and C (p=0.000), PD and C 
(p=0.000) [Table 5, Fig 2] and statistically insignificant value between RT and D 
(p=0.073), D and PD (p=0.400).  
The mean difference of independent variable PPD was statistically significant 
between RT and C (p=0.000), D and C (p=0.000), PD and C (p=0.006) [Table 6, Fig 
3] and statistically insignificant values between RT and D (p=0.827), RT and PD 
(p=0.070), D and PD (p=0.373).  
The mean difference of independent variable CAL was statistically significant 
between RT and PD (p=0.000), RT and C (p=0.000), D and C (p=0.001), D and PD 
(p=0.011) [Table 7, Fig 4] and statistically insignificant values between RT and D 
(p=0.203), PD and C (p=0.699).  
The mean difference of independent variable GBI was statistically significant 
between RT and PD (p=0.018), RT and C (p=0.000), D and C (p=0.000), PD and C 
(p=0.000) [Table 8, Fig 5] and statistically insignificant value between RT and D 
(p=0.125), D and PD (p=0.861). 
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Overall, RT groups shows higher difference in clinical parameters when 
compared to D group, D group shows higher values when compared to PD group and 
PD shows higher value when compared to C group. 
In this study, the mean values of PlI, GI, PPD and GBI was statistically 
insignificant though the mean difference between the groups were significant.  
Clinical changes show all independent variables increases in renal transplant group 
when compared to dialysis and pre dialysis patients. All variables were comparably 
low in control group. Clinical attachment level is the marker of periodontal disease. In 
this study, clinical attachment loss was more in renal transplant group when compared 
to other groups and it was statistically significant. So, there was correlation between 
CRF patients for developing gingivitis and periodontitis. 
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STUDY SAMPLE CHARACTERISTICS 
                           
Table 3. Description of age in study group: 
 
*represent p value (<0.01) which is statistically significant 
§ represent Pearson Chi-Square 
 
 
 
 
 
 
 
  
             CRF TREATMENT GROUPS (n=75) 
  
  
 
Groups 
 
RT 
 
D 
 
PD 
 
C 
 
Total 
 
Number of 
subjects 
 
25 
 
25 
 
25 
 
20 
 
95 
 
Male (%) 
 
20(80%) 
 
14(56%) 
 
18(72%) 
 
13(65%) 
 
65(68.4%) 
 
Female (%) 
 
5(20%) 
 
11(44%) 
 
7(28%) 
 
7(35%) 
 
30(31.6%) 
 
p value § 
 
0.000* 
 
0.000* 
 
0.000* 
 
0.000* 
 
0.000* 
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        Table 4. Description of Gingival Overgrowth 
*represent p value (<0.01) which is statistically significant 
§ represent Pearson Chi-Square 
 
 
 
 
 
 
 
 
 
  
         CRF TREATMENT GROUPS (n=75) 
  
  
 
Groups 
 
RT 
 
D 
 
PD 
 
C 
 
Total 
Number of 
subjects (%) 
 
25(100%) 
 
25(100%) 
 
25(100%) 
 
20(100%) 
 
95(100%) 
Gingival 
overgrowth 
present (%) 
 
13(52%) 
 
3(12%) 
 
1(4%) 
 
0(0%) 
 
17(17.9%) 
Gingival 
overgrowth 
absent (%) 
 
12(48%) 
 
22(88%) 
 
24(96%) 
 
20(100%) 
 
78(82.1%) 
 
p value § 
 
0.000* 
 
0.000* 
 
0.000* 
 
0.000* 
 
0.000* 
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Table 3. Baseline Description of Study Groups (ANOVA) 
Parameters  Groups  Mean  Std.dev Minimum  Maximum  p Value ¶ 
PlI RT 
D 
PD 
C 
1.7096 
1.4032 
1.2872 
0.6075 
0.61304 
0.38021 
0.56015 
0.38872 
0.60 
0.80 
0.20 
0.10 
2.95 
2.10 
2.40 
1.40 
 
 
 
0.036 
GI RT 
D 
PD 
C 
1.8220 
1.5064 
1.3048 
0.5965 
0.55359 
0.38397 
0.50869 
0.29116 
0.80 
0.90 
0.13 
0.10 
2.70 
2.35 
2.40 
1.10 
 
 
 
0.078 
PPD RT 
D 
PD 
C 
3.9708 
3.8084 
3.5016 
2.8250 
0.86901 
0.54516 
0.51569 
0.69953 
1.40 
3.00 
2.63 
1.20 
5.30 
5.30 
4.50 
4.00 
 
 
 
0.306 
CAL RT 
D 
PD 
C 
2.3020 
1.6008 
0.4832 
0.0750 
1.71837 
1.59464 
0.65895 
0.15174 
0.00 
0.00 
0.00 
0.00 
5.70 
5.10 
2.80 
0.50 
 
 
 
0.000* 
GBI 
 
RT 
D 
PD 
C 
2.9268 
2.4728 
2.3124 
1.1960 
0.77163 
0.58966 
0.86214 
0.61029 
1.50 
1.70 
0.20 
0.30 
4.40 
4.40 
4.50 
2.50 
 
 
 
0.476 
*represent p value (<0.01) which is statistically significant 
¶ represent one way analysis by ANOVA 
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Table 4. Comparison of Plaque Index (PlI) between study groups (Tukey Test) 
 
*represent p value (<0.01) which is statistically significant 
ǂ  Tukey HSD test 
∂ represent 95% confidence interval. 
 
 
 
 
 
 
 
 
Independent  
variables 
Groups 
(I) 
Groups 
(J) 
Mean 
difference               
(I –J) 
Lower 
bound ∂ 
Upper 
bound ∂ 
     p value 
ǂ  
PlI RT 
 
D 
PD 
C 
0.3064 
0.4224* 
1.1021* 
- 0.0649 
  0.0511 
  0.7083 
0.6777 
0.7937 
1.4959 
0.142 
0.019* 
0.000* 
 D 
 
RT 
PD 
C 
- 0.3064 
0.1160 
0.7957* 
- 0.6777 
- 0.2553 
0.4019 
0.0649 
0.4873 
1.1895 
0.142 
0.846 
0.000* 
 PD 
 
RT 
D 
C 
-0.4224* 
-0.1160 
0.6797* 
- 0.7937 
- 0.4873 
0.2859 
-0.0511 
0.2553 
1.0735 
0.019* 
0.846 
0.000* 
 C RT 
D 
PD 
-1.1061* 
-0.7957* 
-0.6797* 
-1.4959 
-1.1895 
-1.0735 
-0.7083 
-0.4019 
-0.2859 
0.000* 
0.000* 
0.000* 
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Table 5. Comparison of Gingival Index (GI) between study groups (Tukey Test) 
Independent  
Variables 
Groups 
(I) 
Groups 
(J) 
Mean 
difference 
(I –J) 
Lower 
bound ∂ 
Upper 
bound ∂ 
p value  ǂ  
GI RT 
 
D 
PD 
C 
0.3156 
0.5172* 
1.2255* 
-0.0201 
0.1815 
0.8694 
0.6513 
0.8529 
1.5816 
0.073 
0.001* 
0.000* 
 D 
 
RT 
PD 
C 
-0.3156 
0.2016 
0.9099* 
-0.6513 
-0.1341 
0.5538 
0.0201 
0.5373 
1.2660 
0.073 
0.400 
0.000* 
 PD 
 
RT 
D 
C 
-0.5172* 
-0.2016 
0.7083* 
-0.8529 
-0.5373 
0.3522 
-0.1815 
0.1341 
1.0644 
0.001* 
0.400 
0.000* 
 C RT 
D 
PD 
-1.2255* 
-0.9099* 
-0.7083* 
-1.5816 
-1.2660 
-1.0644 
-0.8694 
-0.5538 
-0.3522 
0.000* 
0.000* 
0.000* 
*represent p value (<0.01) which is statistically significant 
ǂ  Tukey HSD test 
∂ represent 95% confidence interval. 
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Table 6. Comparison of Probing Plaque Depth (PPD) between study groups (Tukey 
Test) 
Independent  
Variables 
Groups 
(I) 
Groups 
(J) 
Mean 
difference 
(I –J) 
Lower 
bound ∂ 
Upper 
bound ∂ 
p value  ǂ  
PPD RT 
 
D 
PD 
C 
0.1624 
0.4692 
1.1458* 
-0.3333 
-0.0265 
0.6200 
0.6581 
0.9649 
1.6716 
0.827 
0.070 
0.000* 
 D 
 
RT 
PD 
C 
-0.1624 
0.3068 
0.9834* 
-0.6581 
-0.1889 
0.4576 
0.3333 
0.8025 
1.5092 
0.827 
0.373 
0.000* 
 PD 
 
RT 
D 
C 
-0.4692 
0.3068 
0.6766* 
-0.9649 
-0.8025 
0.1508 
0.0265 
0.1889 
1.2024 
0.070 
0.373 
0.006* 
 C RT 
D 
PD 
-1.1458* 
-0.9834* 
-0.6766* 
-1.6716 
-1.5092 
-1.2024 
-0.6200 
-0.4576 
-0.1508 
0.000* 
0.000* 
0.006* 
*represent p value (<0.01) which is statistically significant 
ǂ  Tukey HSD test 
∂ represent 95% confidence interval. 
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Table 7. Comparison of Clinical Attachment Level (CAL) between study groups 
(Tukey Test) 
Independent  
variables 
Groups 
(I) 
Groups 
(J) 
Mean 
difference 
(I –J) 
Lower 
bound ∂ 
Upper 
bound ∂ 
p value  ǂ  
CAL RT 
 
D 
PD 
C 
0.7012 
1.8188* 
2.2270* 
-0.2259 
0.8917 
1.2436 
1.6283 
2.7459 
3.2104 
0.203 
0.000* 
0.000* 
 D 
 
RT 
PD 
C 
-0.7012 
1.1176* 
1.5258* 
-1.6283 
0.1905 
0.5424 
0.2259 
2.0447 
2.5092 
0.203 
0.011* 
0.001* 
 PD 
 
RT 
D 
C 
-1.8188* 
-1.1176* 
0.4082 
-2.7459 
-2.0447 
-0.5752 
-0.8917 
-0.1905 
1.3916 
0.000* 
0.011* 
0.699 
 C RT 
D 
PD 
-2.2270* 
-1.5258* 
-0.4082 
-3.2104 
-2.5092 
-1.3916 
-1.2436 
-0.5424 
0.5752 
0.000* 
0.001* 
0.699 
*represent p value (<0.01) which is statistically significant 
ǂ  Tukey HSD test 
∂ represent 95% confidence interval. 
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Table 8. Comparison of Gingival Bleeding Index (GBI) between study groups (Tukey 
Test) 
*represent p value (<0.01) which is statistically significant 
ǂ  Tukey HSD test 
∂ represent 95% confidence interval. 
 
 
 
 
 
 
 
Independent  
variables 
Groups 
(I) 
Groups 
(J) 
Mean 
difference 
(I –J) 
Lower 
bound ∂ 
Upper 
bound ∂ 
p value  ǂ  
GBI RT 
 
D 
PD 
C 
0.4540 
0.6144* 
1.7308* 
-0.0811 
0.0793 
1.1632 
0.9891 
1.1495 
2.2984 
0.125 
0.018* 
0.000* 
 D 
 
RT 
PD 
C 
-0.4540 
0.1604 
1.2768* 
-0.9891 
-0.3747 
0.7092 
0.0811 
0.6955 
1.8444 
0.125 
0.861 
0.000* 
 PD 
 
RT 
D 
C 
-0.6144* 
-0.1604 
1.1164* 
-1.1495 
-0.6955 
0.5488 
-0.0793 
0.3747 
1.6840 
0.018* 
0.861 
0.000* 
 C RT 
D 
PD 
-1.7308* 
-1.2768* 
-1.1164* 
-2.2984 
-1.8444 
-1.6840 
-1.1632 
-0.7092 
-0.5488 
0.000* 
0.000* 
0.000* 
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Fig 1: Comparison of Plaque Index (Pll) between study groups 
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Fig 2: Comparison of Gingival Index (GI) between study groups 
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Fig 3: Comparison of Probing Pocket Depth (PPD) between study groups 
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Fig 4: Comparison of Clinical Attachment Level (CAL) between study groups 
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Fig 5: Comparison of Gingival Bleeding Index (GBI) between study groups 
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A state of immunodeficiency exists in CRF patients are due to altered 
immunity and protein malnutrition.
1
 In CRF patients, various treatment modalities 
make them high risk for infection and bleeding abnormalities. Kshirsagar et al. 
(2007)
43
, Fisher et al. (2008)
45
, Levey et al. (2011)
10 
suggested that, different forms 
of acute and chronic inflammatory processes can stimulate an inflammatory response 
in the kidneys, leading to CRF. Periodontal disease is a chronic infectious disease of 
microbial origin which results in destruction of the tissues housing the tooth and 
ultimately leads to tooth loss. Periodontitis could be considered a non-traditional risk 
for CRF due to the following factors: 
45
 
 (1) Systemic inflammatory burden caused by periodontal inflammation (and its 
locally produced inflammatory mediators, such as IL-1, IL-6, PGE2 and TNFɑ )  
 (2) Presence of bacteria and their products in the bloodstream  
(3) Elevated levels of C-reactive protein, a mild acute-phase systemic inflammatory 
response which acts as a source of “permanent inflammation” that could contribute to 
CRF. 
 With respect to the presence of bacteria in the bloodstream, circulating 
periodontal bacteria could lead to kidney endothelium damage.
25, 19
 It seems 
biologically plausible, that such an association could constitute a source of systemic 
inflammatory burden.
45
The predictive role of inflammatory biomarkers creates a poor 
outcome in CRF patients. 
This study was a multicentered, cross sectional, prospective, parallel design 
and purposive non probability sampling technique was applied. Statistical analysis  
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used in this study was descriptive (frequency), inferential statistics like mean, 
standard  deviation and ANOVA, to examine the significance of the differences 
between the clinical parameters among different groups. When a difference was found 
in ANOVA test, a Tukey Kramer analysis for multiple regression analysis was 
utilized to elucidate which groups were statistically different from the others. The 
Pearson correlation analysis was utilized to examine the significance of the 
correlation between the variables. The statistical analysis was calculated by using 
analysis of variance (ANOVA) and Post Hoc test was applied for multiple 
comparisons. The clinical parameters assessed were PlI, GI, GO, GBI, PPD, CAL in 
patients with CRF under various treatment like renal transplant(RT), dialysis(D) and 
predialysis(PD) [Test group] and compared with systemically healthy subjects 
[Control].  
The inference of the present study showed, the mean values of PlI, GI, PPD 
and GBI were statistically insignificant between the study groups. Test [renal 
transplant(RT), dialysis(D), predialysis(PD)] groups showed clinically increased oral 
parameters when compared with control group, which revealed considerably low 
values. The mean value of clinical attachment loss was statistically significant.  
The present study showed mean value of PlI score in renal transplant(RT) 
group was 1.7096, dialysis(D) group was 1.4032, predialysis(PD) group was 1.2872 
and control(C) group was 0.6075 and it was not statistically significant (p=0.036). 
This result was in accordance with the study by Oshrain et al. (1979)
31
, who found 
mean value of PlI was statistically insignificant.  
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In the current study, the mean difference of independent variable PlI was 
statistically significant between renal transplant(RT) and predialysis(PD) (p=0.019) 
groups, renal transplant(RT) and control(C) groups (p=0.000), dialysis(D) and 
control(C) groups (p=0.000), predialysis(PD) and control(C) groups (p=0.000) and 
statistically insignificant values between renal transplant(RT) and dialysis(D) groups 
(p=0.142), predialysis(PD) and dialysis(D) groups (p=0.846).  
In accordance with the present study, comparing the mean difference of plaque 
index in renal transplant(RT) and predialysis(PD) groups, renal transplant(RT) and 
control(C) groups, Bastos et al. (2011)
64
 found a statistically significant difference. 
Comparing dialysis(D) and control(C)  groups, Sauza et al. (2005)
36
, Castillo et al. 
(2007)
42
, Bayraktar et al. (2007)
39
, Brito et al. (2012)
54
, Davidovich et al. (2005)
6
 
found it to be statistically significant. Comparing predialysis(PD) and control(C) 
group, Davidovich et al. (2005)
6
 found to be statistically significant. Comparing renal 
transplant(RT) and dialysis(D) groups, Oshrain et al. (1979)
31 
found mean difference 
were statistically insignificant. According to Davidovich et al. (2005)
6
, who found 
predialysis(PD) and dialysis(D) groups were statistically insignificant. 
In contrast to the present study, Davidovich et al. (2005)
6
 found statistically 
insignificant difference between renal transplant(RT) and predialysis(PD) groups. 
Oshrain et al. (1979)
31
, Kardachi et al. (1978)
30
, Davidovich et al. (2005)
6
 found 
statistically insignificant between renal transplant(RT)  and control(C)  groups. 
Frankenthal et al. (2002)
67
, Marakoglu et al. (2003)
1
, Bots et al. (2005)
37
, 
Borawski et al. (2007)
41
, Oshrain et al. (1979)
31
found a statistically insignificant 
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difference between dialysis(D) and control(C)  groups. Borawski et al (2007)
41
, 
Artese et al. (2011)
49
, Bastos et al (2011)
64
, Vilela et al. (2011)
53
 found statistically 
insignificant difference between predialysis(PD) and control(C) groups. Davidovich 
et al. (2005)
6
 found statistically significant difference between renal transplant(RT) 
and dialysis(D) groups. The result of the present study highlighted PlI was higher in 
test group when compared to control group. To overcome increased levels of plaque 
accumulation, regular periodontal care, non surgical periodontal therapy and 
maintenance is indicated in CRF patients. 
In the present study, the mean values of GI in renal transplant(RT), 
dialysis(D), predialysis(PD), control group(C) was 1.8220, 1.5064, 1.3048, 0.5965 
respectively and these values were also statistically insignificant (p=0.078). This 
result was in accordance with the study by Oshrain et al. (1979)
31
, who found mean 
value of GI was statistically insignificant. 
 The mean difference of independent variable GI was statistically significant 
between renal transplant and predialysis(PD) groups (p=0.001), renal transplant(RT) 
and control(C) groups (p=0.000), dialysis(D) and control(C) groups (p=0.000), 
predialysis(PD) and control(C) groups (p=0.000) and statistically insignificant value 
between renal transplant(RT) and dialysis (D)groups (p=0.073), dialysis(D) and 
predialysis (PD) groups (p=0.400). 
 In accordance with the present study, comparing the mean difference of 
gingival index, Davidovich et al. (2005)
6
 found the renal transplant(RT)  and 
predialysis groups(PD), renal transplant(RT)  and control(C) groups, dialysis(D) and 
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control (C)groups, predialysis(PD) and control(C) groups were statistically 
significant. Bayraktar et al. (2007)
39
, Kardachi et al. (1978)
30
 stated statistically 
significant difference between renal transplant(RT)  and control(C) groups. Sauza et 
al. (2005)
36
 who compared dialysis(D) and control(C) group and found to be 
statistically significant. Joseph et al. (2009)
46
 compared predialysis(PD) and 
control(C) groups and found to be statistically significant. Davidovich et al. (2005)
6
 
compared renal transplant(RT)  and dialysis(D) groups were statistically insignificant. 
In contrast to the present study, Marakoglu et al. (2003)
1
, Frankenthal et al. 
(2002)
67
 compared dialysis(D)  and control(C) groups were statistically insignificant.                         
Davidovich et al. (2005)
6
compared dialysis (D) and predialysis (PD) groups and 
found to be statistically significant. Gingival inflammation has been reported, due to 
plaque accumulation and poor oral hygiene. Increased plaque accumulation has the 
potential to increase the inflammatory component of gingival disease in patients with 
renal failure. 
The mean difference of independent variable PPD was statistically significant 
between renal transplant(RT) and control(C) groups (p=0.000), dialysis(D)  and 
control(C)  groups (p=0.000), predialysis(PD)  and control(C)  groups (p=0.006) and 
statistically insignificant values between renal transplant(RT) and dialysis(D)   groups 
(p=0.827), renal transplant(RT)  and predialysis(PD)   groups (p=0.070), dialysis(D)   
and predialysis(PD)   groups (p=0.373).  
In accordance to the present study, Davidovich et al. (2005)
6
, who found the 
mean difference of PPD in renal transplant(RT)  and control(C)   groups, dialysis(D)   
and control(C)   groups, predialysis(PD)  and control(C)   groups were statistically 
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significant. When comparing predialysis(PD)   and control(C)   groups, Joseph et al. 
(2009)
46
, Vilela et al. (2011)
53
 found that mean difference was found to be 
statistically significant. 
In contrast to the present study, Bayraktar et al. (2003)
39
, Bots et al. (2005)
37
   
Marakoglu et al. (2003)
1
, Frankenthal et al. (2002)
67
 examined dialysis(D) and 
control(C) groups and found it to be statistically insignificant. However, current study 
finding revealed periodontal pockets were significantly deeper in the CRF groups than 
in the control indicating a different mechanism of periodontal disease in CRF patients. 
Furthermore, the significant correlation between periodontal pockets and the duration 
of renal failure suggests that prolonged renal dysfunction has a direct effect on the 
progression of periodontal disease. 
Among all the clinical parameters, the mean value of CAL was statistically 
significant (p=0.000) and the mean difference of independent variable CAL was 
statistically significant between renal transplant(RT) and predialysis(PD) groups 
(p=0.000), renal transplant(RT) and control(C) groups (p=0.000), dialysis(D) and 
control(C) groups (p=0.001), dialysis(D) and predialysis(PD) groups (p=0.011) and 
statistically insignificant values between renal transplant(RT) and dialysis(D) groups 
(p=0.203), predialysis(PD) and control(C) groups (p=0.699).  
In accordance with the present study, Bastos et al. (2011)
64
 who found 
statistically significant of attachment loss in predialysis(PD) and renal transplant(RT) 
groups. Davidovich et al. (2005)
6
, Bastos et al. (2011)
 64
 found renal transplant(RT) 
and control(C) groups were statistically significant. Parkar et al. (2012)
68
, Borawski 
et al. (2007)
41
, Brito et al. (2012)
54
 compared dialysis(D) and control(C) group and 
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found it to be statistically significant. When comparing predialysis(PD) and 
control(C) groups, Bastos et al. (2011)
 64
, Artese et al. (2010)
49
 found the mean 
difference was statistically insignificant. 
 In contrast to the present study, Vilela et al. (2011)
53
, Brito et al. (2012)
54
,                 
Davidovich et al. (2005)
6
 compared predialysis(PD) and control(C) group and found 
to be statistically significant. Castillo et al. (2007)
42
, Joseph et al. (2009)
46
 found 
statistically insignificant mean difference between dialysis(D) and control(C) groups. 
Clinical attachment loss which denotes the presence of periodontitis, was higher in 
CRF patients compared to control subjects. These findings suggest that attachment 
loss may be influenced by the uraemic status and its duration. 
The mean difference of independent variable, GBI, was statistically significant 
between renal transplant(RT) and predialysis(PD) groups (p=0.018), renal 
transplant(RT) and control(C) groups (p=0.000), dialysis(D) and control(C) groups 
(p=0.000), predialysis(PD) and control(C) groups (p=0.000) and statistically 
insignificant value between renal transplant(RT) and dialysis(D) groups (p=0.125), 
dialysis(D) and predialysis(PD) groups (p=0.861).  
In accordance with the present study, Davidovich et al. (2005)
6
, stated that 
BOP was statistically significant between renal transplant(RT) and control(C) groups, 
dialysis(D) and control(C) groups, predialysis(PD) and control(C) groups. Brito et al. 
(2012)
54
 found statistically significant difference between predialysis(PD) and 
control(C) groups. Borawski et al. (2007)
41
 found statistically significant difference 
between dialysis(D) and control(C) groups.  
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In contrast to the present study, Artese et al. (2010)
49
, Bostos et al. (2011)
 64
, 
Vilela et al. (2011)
53
found statistically insignificant between predialysis(PD) and 
control(C) groups. Brito et al. (2012)
54
, Castillo et al. (2007)
42
 found statistically 
insignificant gingival bleeding between dialysis(D) and control(C) groups. From this 
study it was revealed that gingival bleeding was more in test group when compared 
control(C) group. Bleeding on probing was examined separately from GI because of 
coagulation disturbances in CRF patients (impaired thrombocyte function and heparin 
administration during dialysis in transplanted patients). In the present study, bleeding 
sites prevalence was significantly higher in the CRF groups as compared to the 
controls(C) who had normal coagulation (the dialysis group showing the highest 
gingival bleeding prevalence). This finding may be related to more severe gingival 
inflammation and/or coagulation disturbances in CRF patients. However, one should 
take in consideration that the examination was performed 1 h after dialysis. Therefore, 
the patients were heparinized and the urea reduction was not enough to improve 
thrombocytes function). 
In the present study, presence of gingival overgrowth was statistically 
significant in renal transplant patients and this was due to intake of calcium channel 
blockers. 52% (n=13) of renal transplant (RT) patients, 12% (n=3) dialysis(D) 
patients and 4% (n=1) predialysis(PD) patients showed significant amount of gingival 
overgrowth. No patients in the control group (C) (0%, n=0) had gingival overgrowth. 
This result was supported by Davidovich et al. (2005)
6
, where he found the renal 
transplant group showed higher gingival overgrowth and slight increase in predialysis 
and dialysis groups and it was statistically significant. This study showed that gingival 
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overgrowth was prevalent in test group and completely absent in control(C) group. 
Extensive gingival overgrowth was found in transplanted patients due to the use of 
cyclosporine, and most likely also related to the use of calcium channel blockers and 
poor oral hygiene in the predialysis and dialysis patients. 
According to present study, test group showed increase in plaque 
accumulation, gingival inflammation, loss of attachment, bleeding on probing and 
gingival overgrowth when compared to control(C) group and the mean difference 
between test and control(C) group was statistically significant. This indicates a direct 
association between the CRF patients and periodontitis. The issues of poor oral health 
status deserve dental awareness in CKF patients. Since, the periodontal status gets 
worsened in CRF patients, early periodontal examination and oral prophylaxis should 
be considered as an integral part of treating these patients. 
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 Bacterial plaque is the primary etiological factor for periodontal disease and 
along with that, the systemic factors/conditions of the host will also alter the 
prevalence, progression and severity of periodontal diseases. CRF patients present a 
complex clinical problem with multisystem involvement, including oral disease and 
some systemic conditions like anemia, increased liability to bleeding, cardiovascular 
disease, but with the use of well supervised diagnosis and treatment protocol, 
management of these individuals will be effective and safe. The CKD patient with 
periodontitis is medically complex and presents the dental practitioner with several 
challenges in the management of their periodontal condition. Accordingly, close 
communication between the dentist and nephrologist is essential to optimize 
periodontal management. Comprehensive clinical investigation of periodontal disease 
in CRF patients are needed to gain new insight about dental awareness and to improve 
their oral health. 
This study evaluates the oral and periodontal status of chronic renal failure 
patients undergoing predialysis (PD), dialysis (D) and renal transplant (RT). The 
study includes 75 cases of chronic renal failure patients compared with 20 healthy 
individuals with age ranging more than 35years. The test group consists of three 
groups based on their treatment. Group-I comprised of 25 patients who were on 
predialysis, Group-II comprised of 25 patients who were on dialysis, Group-III 
consists of 25 patients who were underwent renal transplant.  The control group 
consists of 20 patients were included in the control group without any systemic 
disease. Test group were selected in the Department of Nephrology, Sri Ramakrishna 
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Hospital, Coimbatore and Coimbatore Kidney Center, Coimbatore and controls obtain 
from Department of Periodontology, Sri Ramakrishna Dental College and Hospital, 
Coimbatore. 
  In this study, the clinical parameters PlI, GI, PPD, CAL, GBI, GO were 
assessed. The mean value of PlI, GI, PPD, GBI were statistically insignificant but 
CAL was statistically significant. When considering the mean difference between the 
groups, all clinical parameters were statistically significant. The finding of the study 
showed that the test group showed increase in plaque accumulation, gingival 
inflammation, bleeding on probing, loss of attachment and gingival overgrowth when 
compared to control group. This indicates CRF patients were more prone for 
progression of periodontal disease. Hence, there is a relationship that exists between 
CRF patients and periodontitis. Therefore, maintaining good oral health is of major 
importance since oral pathologies or infections could jeopardize the opportunity to 
receive a successful kidney transplant.  
There is still a long way to discover the relationship between CRF and 
periodontal disease. Limitation of this study was its cross-sectional design and smaller 
sample size. Therefore, further longitudinal studies with larger sample size, 
comparison of pre and post periodontal treatment has to be assessed. 
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